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ABSTRACT 
Background: Alcohol use disorders (AUD) affect health and wellbeing, and have 
broad societal costs (Bouchery, Harwood, Sacks, Simon, & Brewer, 2011; Rehm et al., 
2009; Sudhinaraset, Wigglesworth, Takeuchi, & Tsuker, 2016). While treatments have 
existed for decades, they are limited in success and expensive to administer. As such, 
understanding which factors best predict who will benefit most from treatment remains 
a laudable goal. Prior attempts to predict factors associated with positive treatment 
outcome are limited by methodology including statistical methods that lead to poor 
predictive power in new samples. This study aims to use a data-driven approach to 
clarify the predictors of AUD treatment success (Objective 1) accompanied by a 
theory-driven analysis assessing the mediation of treatment outcomes through 
psychological distress (Objective 2). Methods: One hundred forty-five patients seeking 
treatment for alcohol use problems at the Day One Intensive Outpatient Treatment 
Program (part of UVM Medical Center) between June 2011 and June 2012 were 
examined. Variables were extracted through chart review and were categorized using 
the Bronfenbrenner Ecological Model.  First, 20% of the sample was set-aside for 
model testing, and the remaining 80% was used in an Elastic Net Regularized linear 
regression, with 10-fold cross validation. Models were tested on the set-aside sample to 
yield estimates of out-of-sample prediction and repeated models were compared to 
ensure generalizability. Next, a theoretical model was tested examining a model of 
psychological distress mediating the relationship between individual predictors and 
treatment outcome. Results: The models developed from the Elastic Net Regularization 
approach demonstrated consistency in model strength (mean=0.32, standard 
deviation=0.03) with models ranging from 14 to 31 included variables. Across the 
models, 15 variables occurred in >75% of the models, and an additional 7 variables 
were included in 25% - 75% of the models. Some of the strongest predictors included 
treatment non-compliance (β=-0.92), ASI Alcohol Composite (β=0.63), treatment 
dosage (β =-0.36), and readiness to change (β=-0.95). The results of the theory-driven 
mediation analysis demonstrated several strong direct predictors of outcome frequency 
of alcohol use, including readiness to change (β=-0.59), initial frequency of alcohol use 
(β=0.27), and access to a primary care physician (β=-2.20). The theoretical model 
found that none of the mediation pathways (testing psychological variables) were 
significantly different from the direct models. Conclusions: This study used both data- 
driven and theory-driven methods to examine factors affecting treatment of AUDs. The 
application of data-driven methods provided several predictors of outcome that can 
guide treatment efforts within Day One IOP treatment, as well as generalized to other 
abstinence-based treatment settings. For example, focusing on treatment attendance and 
using motivational interviewing to enhance readiness to change are methods supported 
by this study. Demographic variables that have been shown to predict treatment 
outcome in small studies, without cross-validation were not identified by the elastic net 
regression (e.g., age and gender). It is suspected that this is due to model overfitting in 
prior studies supporting the importance of using generalizable statistical methods to 
understand predictors of treatment outcome. This notion is supported by the results of 
the theory-driven model, which did not yield a strong model of treatment success. 
Taken together, the results support the use of strong analytic techniques which will 
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Introduction, Research Questions, and Hypotheses 
With approximately 15.7 million people diagnosed with an Alcohol Use Disorder 
(AUD) in the United States alone, the development of effective treatments has remained 
an issue of national importance. The financial costs of AUDs have included health related 
expenses, with severe patterns of alcohol use worsening other chronic health conditions 
(Rehm et al., 2009), as well as added stress on finances, interpersonal relationships, 
housing and educational/career progression. Additionally, there have been numerous 
societal costs due to loss of productivity, increased demand on the criminal justice 
system, and intentional/accidental damage to persons or property associated with AUDs 
(Bouchery et al., 2011; Sudhinaraset et al., 2016). These costs have driven research aimed 
at understanding AUD treatment, including reduction of the severity of current alcohol 
use and ultimately long-term remission from use. 
Many treatments exist, and although research has indicated a significant reduction 
in use following an array of treatments, relapse has remained a central problem affecting 
between 40% and 60% of treatment completers. Recurrence of use has varied widely with 
a range of factors across psychological and sociological domains being shown to 
influence the success and failure of treatment. Adamson, Sellman, and Frampton (2009) 
have found factors that consistently predict treatment outcomes, including demographic 
(gender, employment, SES), substance-use (motivation to change and severity of use), 
and psychological (rating of anxiety, rating of depression, and overall psychiatric 
severity) variables. In addition, literature examining the impact of an individual’s social 
context on treatment outcome has supported several additional predictors, including 
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general family social support, general friend social support, and changes in specific social 
support for alcohol use (Best & Lubman, 2017; McCutcheon et al., 2013). 
Despite these advancements in predicting an individual’s likelihood of successful 
treatment, notable limitations have remained in the consistency and generalizability of 
predictors. The inconsistencies in predictive variables found in Adamson et al.’s (2009) 
meta-analysis suggest that past analytical methods have relied too heavily on the 
relationship between variables within a single study sample (overfitting). The problem of 
representativeness is impacted by frequent utilization of “clean samples” of patients (i.e. 
alcoholics without comorbid psychiatric disorders) and “ivory tower” treatment protocols 
(i.e., highly regulated and reimbursed) that have limited predictive utility within the 
setting of community-based treatment. Even within studies that have utilized a 
community sample, research generally has focused on a single treatment approach, such 
as Alcoholics Anonymous, that fails to reflect the multi-modal approach available in 
most community based treatment programs (Blonigen, Timko, Finney, Moos, & Moos, 
2011; Blonigen, Timko, & Moos, 2013). A final limitation of the current research has 
been a sparsity of clinically meaningful models of the process of recovery. There has 
been clear support from the literature for an impact of multiple forms of psychological 
distress (e.g., anxiety, impulsivity, and personality features) on treatment engagement and 
completion (Burns, Teesson, & Neill, 2005; Glass, Williams, & Bucholz, 2014; Grant, 
Goldstein, Saha, Chou, Jung, Zhang, Pickering, Ruan, Smith, Huang, Hasin, et al., 2015). 
As such, examining theoretically derived predictors within a community sample may help 
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to identify and understand the role of mental health in the process of recovery for patients 
in community-based treatment. 
The proposed study aims to utilize an alternative analytic method (the Elastic Net 
Regularization approach) to accurately identify predictors of treatment success in a 
sample of clients who have sought treatment for alcohol use disorders at an outpatient 
treatment clinic. The Day One clinic, associated with the University of Vermont Medical 
Center, has utilized an integrated, intensive outpatient treatment model providing 
evidence-based interventions for both alcohol use and other highly co-occurring 
disorders. Further, we aimed to examine the concordance of a theoretically-driven model 
that supported the prediction of treatment effectiveness among individuals seeking 
treatment for abnormal alcohol use. 
Objective 1: This study has employed a data-driven methodology to examine the 
predictors of AUD treatment outcome within a community sample representative of 
outpatient treatment facilities within Vermont. Demographic, substance-use, sociological, 
and psychological variables have been used to identify significant predictors of 
reductions in the frequency of alcohol use. The Elastic Net Regularization approach in 
combination with cross-validation acts to prevent model overfitting by estimating the 
accuracy of ‘significant’ variables and strength of generalizability to other treatment 
samples. 
Objective 2: Based on the strong relationships between psychological distress and 
treatment outcome seen in the literature, we have additionally tested a theoretical model 
of successful treatment. (Figure 2). We expect this theory-driven analysis to demonstrate 
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psychological distress as a mediator of the relationship between treatment outcome and 




Our societal conceptualization of alcohol use disorders (AUDs) has shifted from a 
view that alcohol problems reflect a person’s character (e.g. “moral failure”); to a 
medical model of a disease process (Stolberg 2006). These beliefs have been reflected in 
treatment approaches. For example, beliefs based on moral failure led to treatments that 
segregated patients from society (e.g., inebriate asylums typically employed pre-1800s), 
while a belief in the biological underpinnings of addiction led to the public’s 
susceptibility to ‘sham’ cures (e.g.,, the infamous Keely Cure in the late 1890s). Keeley’s 
cure consisted of injections of bichloride of gold, and he claimed that drunkenness "is a 
disease and I can cure it" (p. 68; Tracy, 2005), “unless [patients re-created] it by returning 
to their use, thus re-poisoning [their] nerve cells,” (Hanson, 2011). Current treatments 
have reflected a belief that alcoholism remains a chronic illness which can be treated with 
a combination of lifestyle changes and medical treatments. Though attempts to segregate 
patients in recovery away from society still occur (i.e. long-term hospitalization), the 
integration of treatment into the community has become the norm, including short-term 
residential alcohol treatment facilities and the integration of screening/treatment into the 
primary medical care setting (Rehm et al 2016). However, treatments have remained less 
than fully effective, with broad estimates of success being only 40-60% of clients (NIDA, 
2012). This lack of success has led to AUD treatment research focused on identifying 
sub-groups of problem drinkers (i.e. females, adolescents, the elderly, and those with 
certain comorbid illnesses) who have benefitted from tailored treatment. 
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For example, Project Matching Alcoholism Treatment to Client Heterogeneity 
 
[MATCH], attempted to identify individual characteristics that predict treatment success 
(Arch, 1998). The Project MATCH collaborative study group collected information 
across ten client characteristics shown to impact alcohol use. These included: severity of 
alcohol involvement, cognitive impairment, client conceptual level, gender, meaning 
seeking, motivational readiness to change, psychiatric severity, social support for 
drinking and/or abstinence, sociopathy, and pattern of alcohol use. However, this 
landmark study found that the randomization of characteristics of clients to treatment 
type did not significantly improve treatment outcome (Longabaugh & Wirtz, 2001). A 
provocative meta-analysis examined 55 trials for patient characteristics related to 
treatment success. They found the number of statistical tests for interactions was the only 
significant predictor of the number of significant associations found in a study (Moyer, 
Finney, Elworth, & Kraemer, 2001). This was consistent with the observation of Whelan 
and Garavan (2014), that model overfitting has greatly limited the predictive utility of 
much of the current literature. Thus, despite years of research aimed to improve 
outcomes, the effectiveness of AUD treatment has not improved. 
The AUD treatment literature has remained full of studies containing 
methodological flaws that inherently limit generalizability. For example, Sugarman and 
colleagues (2013) used a path analysis to assess the predictors of change in use (mean 
number of drinks per day) within a sample of 99 individuals. They initially hypothesized 
a mediational model, with marital status, gender, drinking severity, educational level, 
depression, and history of sexual abuse working through self-efficacy and social support 
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to predict changes in use. Though the hypothesized model was shown not to be 
significant, the researchers included an additional path through education level that 
ultimately improved the model fit. This post-hoc model adjustment would exemplify the 
issue of over-fitting a statistical model within a single study sample. Hypothesis pre- 
registration has been suggested as one step that can be taken to reduce Type I (false 
positive) errors in clinical trials (Kaplan & Irvin, 2015). Kaplan and Irvin (2015) reported 
that following the requirement of hypothesis pre-registration, positive findings in studies 
of treatment for heart disease fell from 57% to 8%. In addition, challenges to replication 
and generalizability has led to the development of analytic techniques to improve the 
rigor of predictive modeling, including bootstrapping, permutation, and cross-validation. 
Each of these techniques have included explicit tests of generalizability by either 
resampling the data or testing the model on a set-aside portion of the original data. 
The current study has used a data-driven approach to identify variables that affect 
the success of outpatient treatment for Alcohol Use Disorders (AUDs). Treatment 
outcomes from one year of patients seen at the University of Vermont’s Day One clinic – 
an outpatient clinic for the integrated treatment of substance use and comorbid 
psychiatric problems – were examined such that factors predicting treatment outcomes 
were identified. In addition to this bottom-up model derivation, we have tested a (pre- 
specified) theoretically-driven predictive model which examined the influence of 
psychological distress on treatment outcomes. 
Prior to examining the trajectories of patients through treatment, several areas of 
background literature need to be examined. First, to better understand psychological 
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disorders, such as AUDs, this paper presents a review of relevant frameworks and 
discusses the selected model which supports heterogeneity within etiology, a hallmark of 
AUDs. Second, this framework was used to review factors that influence the initiation of 
unhealthy alcohol use. Third, the literature on factors impacting treatment outcomes was 
reviewed. Finally, this paper has applied this theoretical model, hypothesizing the 
relationship between psychological distress and treatment outcome, keeping in mind the 
context of several barriers to generalization (e.g., single treatment and single cohort). 
 
 
Frameworks within psychology 
 
Recognition of the complexity of factors contributing to unhealthy alcohol use has 
led to broad theoretical frameworks such as the bio-psycho-social model (Engel, 1980). 
The bio-psycho-social model has assumed three basic principles in the process of having 
integrated multiple levels of information about behavior. These three principles were: 1) 
abnormal behavior was complex, 2) one theoretical model would be insufficient, and 3) 
integration of information was necessary (Griffiths, 2005). Though various fields of 
research have had greater and lesser success incorporating multiple levels of information, 
Griffiths (2005) suggested that within the field of AUD, “research and clinical 
interventions are best served by a biopsychosocial approach that incorporates the best 
strands of contemporary psychology, biology and sociology.” As such, there has been a 
call for research to begin uniting these fields in order to develop a working, integrated 
model of problematic alcohol use. 
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In the field of AUDs, a strong background literature has been developed within 
each discipline (biology, psychology and sociology). For example, research on the 
biological mechanisms of AUDs has provided insight into the heritability (Kreek, 
Nielsen, Butelman, & LaForge, 2005; Kreek, Nielsen, & LaForge, 2004; Pinto & 
Ansseau, 2009; Verhulst, Neale, & Kendler, 2015) and neurobiological alterations that 
may have been specific to AUDs (Porjesz & Rangaswamy, 2007; Whelan et al., 2014). 
However, recognizable limits to integrating the biological, psychological and sociological 
factors related to AUDs have remained. These have included a simple lack of 
interdisciplinary efforts, wide variability in defining patterns of “abnormal” alcohol use, 
disagreement surrounding causality, and even inconsistency in the definition of 
successful treatment for AUDs. 
Research on the initiation of alcohol use has long examined the psychological and 
sociological factors that contribute to the development of an AUD. Studies have 
examined factors within the individual that have contributed to alcohol use, including 
alcohol-related beliefs, motivations for use, and behaviors associated with use. 
Additionally, it has been acknowledged that the choices of an individual are commonly 
impacted by their immediate environment, social relationships (peers and family, 
particularly) and beliefs about alcohol use held by societal/cultural groups. As is common 
across psychological disorders, no single predictor has been associated with a ‘tipping 
point’ into the development of problematic use. Instead, individual components have 
been shown to increase the likelihood of patterns of use that eventually contribute to 
problematic use. However, to organize the delivery of each of the relevant constructs 
10  
Bronfenbrenner's ecological model was used as a framework (Figure 1). This paper has 
expanded on the work of Sudhinaraset, Wigglesworth, & Takeuchi (2016). This model 
breaks down factors that have influenced complex behavior as occurring at different 
levels. Relevant to alcohol use, this has included psychological processes (Individual 
level), the influence of the immediate environment and relationships (Microsystem level), 
the influence of community-level beliefs and practices (Mesosystem level), and the wider 
impacts of society (Macrosystem level). 
Bronfenbrenner’s ecological model was selected for examining factors 
contributing to abnormal alcohol use for several reasons. First, the degree of overlap with 
Engel's (1980) Bio-Psycho-Social model signified symmetry in understanding. Secondly, 
both models have suggested that the understanding of a complicated problem, such as 
initiation of abnormal alcohol use, involves examination at each level of the system. 
Finally, this model has allowed for multiple points of contact, or non-linear paths, 
between each level of the system. Thus, it has the capacity to accommodate the complex 
interactions within and between levels seen in the literature. This paper has addressed the 
ongoing need for research that initiates a conversation about how personal, interpersonal, 
community, and systems-level factors impact alcohol use as it relates directly to the 




Figure 1: Engel’s representation of the Bio-Psycho-Social Model (Engel, 1980) and Bronfenbrenner's ecological 




Epidemiology of Alcohol Use Disorders: Overview 
 
According to the 2015 National Survey on Drug Use and Health (NSDUH; Center 
for Behavioral Health Statistics and Quality, 2016) there were 138.3 million current (past 
30 day) alcohol users (representing 51.7% of the population) in the United States. Of 
these, 48.2% reported binge-use (4+ or 5+ drinks on one occasion for females and males, 
respectively) that became ongoing high levels of use in 17.3 million individuals. The high 
occurrence of use and tendency towards problematic patterns of use has led to 15.7 
million individuals diagnosed with an AUD in the past year (Center for Behavioral 
Health Statistics and Quality, 2016). 
From this data, many trajectories of drinking behavior have become apparent. 
This has included time-limited periods of alcohol use (e.g., adolescent experimentation 
and young adult binge-use), maintained limited use, and uncontrolled use commonly 
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those with an AUD, a range of predictors (social, psychological, and biological) have 
contributed to both the initiation of problematic use and the remission of an AUD. Below, 
we have reviewed the literature for factors associated with developing an AUD, and then 
the limited research on factors that have influenced the likelihood of engaging in and 
completing treatment. Prior to this review, the definition of several key terms relevant to 
this literature have been presented. 
 
 
Definition of Terms: 
 
The substance use field has used many terms to describe patterns of alcohol use 
(e.g., abnormal use, concerning use, problematic use, binge drinking, alcohol abuse, 
alcohol dependence, and alcohol use disorder). Each of these terms has represented 
significant differences in the description of an individual’s pattern of alcohol use; 
however, the plethora of terms continues to limit the ability to communicate effectively to 
a wider audience. As this paper has focused on individuals seeking treatment for a wide 
range of patterns of ongoing alcohol use, we have selected to utilize the term 
‘“unhealthy” alcohol use’ to encompass abnormal/concerning/problematic use, binge 
drinking, and alcohol abuse/dependence/disorder (see Table 1 within Saitz, 2005). 
Similarly, several terms have been used to express changes in alcohol use (e.g., 
remission, partial abstinence, full abstinence, lapse, relapse, and controlled drinking). 
Again, these terms have been used to describe separate trajectories as individuals attempt 
to reduce or eliminate alcohol use. In addition, they inherently integrate criteria required 
for a diagnosis of alcoholism. This includes the amount of use, frequency of use, impact 
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on functioning (e.g., social, work, etc.), and recovery goals (e.g., abstinence, harm- 
reduction, etc.). This paper has selected ‘recovery from use’ to incorporate reductions in 
alcohol use, moderated use, abstinence, engagement in services, and improvement in 
overall functioning. These terms have been employed generally unless a need for greater 
specificity was clearly identified. 
Because a wide variety of “yardsticks of success” have been used in the 
assessment of treatment for alcohol use (Sobell, Sobell, Connors, & Agrawal, 2003), we 
have critically examined how the field defines and measures successful treatment. Sobell, 
Sobell, Connors, & Agrawal (2003) summarized that capturing abstinence and 
improvement over time in “acute alcohol-related problems” were of utmost importance. 
Anton & Randall (2005) also acknowledged the merit of, "…outcome measures [which] 
reflect both abstinence and some evaluation of relapse to heavy daily drinking." Despite 
recommendations from the National Institute on Alcohol Abuse and Alcoholism 
(NIAAA) to use the percentage of heavy drinking days, researchers have made their own 
arguments for a variety of other outcome variables (Allen, 2003). For example, Anton 
and Randall (2005) assessed percentage of days abstinent and time to first heavy drinking 
day, Stevens and colleagues (2014) used engagement in treatment and level of use, and 
Newton-Howes, Foulds, Guy, Boden, & Mulder (2017) employed several metrics, 
including time to relapse, drinks per drinking day (DDD), percentage of days drinking 
(PDD) and percentage of days with heavy drinking (PHDD). Despite recommendations 
for outcome variables like PHDD (Allen, 2003), an official consensus has not yet been 
achieved. 
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The methods of measuring drinking behavior have continued to evolve, which has 
contributed to indecision in variable selection. Sobell and colleagues (2003) noted a 
dramatic increase in reliability following a shift from self-reported retrospective estimates 
of alcohol use (e.g., Quantity-Frequency and Lifetime drinking methods) to validated 
self-report measures and/or structured interviews. Newer methods that have assessed both 
the amount and frequency of alcohol use include concurrent recall (CR) and daily 
drinking estimation (DDE). The CR protocol collected alcohol use information during or 
shortly after use, which would result in more accurate reporting than DDE measures of 
use over the recent past (Time-Line Follow-Back [TLFB] and Form 90). Both methods 
have provided an accurate depiction of use, which allowed researchers to operationalize 
outcome variables. 
In recognition of the complexity of treatment outcomes, researchers such as Cisler 
& Zweben (1999) have developed composite measures which incorporated continuous 
variables (e.g., frequency and amount of use) with measures of function (problems 
associated with unhealthy alcohol use). Zweben and Cisler's (2003) brief assessment via 
the 8-item, Form 90-Quick (Miller, 1996) and the 15-item, Short Index of Problems 
(Miller, Tonigan, & Longabaugh, 1995) have resulted in the successful categorization of 
patterns of unhealthy alcohol use (abstinent, moderate use with problems, heavy use or 
problems, and heavy use with problems). This approach has been useful in grouping 
individuals following the completion of treatment associated with remission (abstinence 
or non-problematic moderate drinking) status (30% that remitted, 36% non-remitted, and 
34% unstably remitted), and noting the joint impact of alcohol use and alcohol-related 
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problems (Zweben & Cisler, 2003). Categorical outcome variables have been problematic 
because: 1) functioning challenges included in the measure likely confound the influence 
of psycho-social problems on alcohol use behaviors and 2) they provided no better 
differentiation on the trajectories of recovery following treatment (i.e. 70% with unstable 
or non-remitted status). Therefore, a metric of success reflecting alcohol consumption, 
such as the quantity and/or frequency of use, has remained a preferred way to evaluate 
treatment outcomes. 
 
Thus, the primary outcome variable selected for this study was the frequency of 
alcohol use when treatment was terminated (number of drinks/month during the month 
prior to discharge). Though the data was not collected using an standardized measure 
(e.g., concurrent recall or timeline follow-back), a standardized assessment was 
conducted by a trained clinician in alignment with Vermont requirements for reporting 
patient outcomes (i.e., description of use of alcohol within the past month). It is notable 
that several alternative outcome variables have been collected within this dataset 
(including metrics of treatment engagement, overall functioning at outcome, etc.). We 
believe, however, that this co-assessment by client and clinician of the frequency of use 
(e.g., None, 1-3/month, 1-2/week, 3-6/week, and daily use) represented the most reliable 
indicator of treatment outcome which has remained consistent with metrics utilized 
within past literature. 
 
 




The first level of the Bronfenbrenner model focuses on individual characteristics 
related to (in this case) patterns of unhealthy alcohol use. This section has reviewed 
several factors that contribute to the development of these patterns of use. These factors 
have spanned across the internal sensations associated with alcohol use, the cognitions 
regularly used to reinforce use, the emotional states (temporary and ongoing) that become 
paired with use behaviors, and the demographic variables which have gently reinforced 
use. The ultimate goal of this section was to develop a sense of the internal world for 
individuals engaging in alcohol use. 
From the moment alcohol has been ingested it begins to influence the individual 
with both stimulating and depressant effects that depend both on the dose of alcohol 
consumed and the length of time since consumption (Brabant, Guarnieri, & Quertemont, 
2014). Individuals with greater sensitivity to the stimulating effects and reduced 
sensitivity to the sedating effects of alcohol have been shown to be at risk for unhealthy 
alcohol use (King, McNamara, Hasin, & Cao, 2014). This concept has consistency with 
the first portion of the Hedonic Hypothesis which suggested that the pleasurable effects 
of alcohol initially motivate use. This influence has the ability to change with time, 
however, and eventually becomes replaced by a need to relieve/prevent the experience of 
withdrawal, particularly the experience of negative affect (Cheetham, Allen, Yücel, & 
Lubman, 2010; Robinson & Berridge, 2003; Sher et al., 2005). 
Baker and colleagues (2004) suggested that early withdrawal symptoms bias 
information processing, via subconscious processing of the environment, towards alcohol 
and drug-related stimuli. Use becomes facilitated by these stimuli as a result of an 
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increased likelihood of drinking in response to early withdrawal, ultimately leading to 
negative reinforcement (Breese, Sinha, & Heilig, 2011; Fox, Bergquist, Hong, & Sinha, 
2007; Ryan, 2002). The influence on attentional biases have also been shown to be 
moderated by an individual’s emotional experiences separate from occasions of use. 
Increased negative affect and difficulty regulating affective states both contribute to 
internalizing symptoms. Further, internalizing symptoms have been associated with an 
increased likelihood of unhealthy alcohol use (Pandina, Johnson, & Labouvie, 1992). As 
such, both the experience of and immediate response to negative affect (either 
subconscious enhancement of drinking-related cues or conscious activation of beliefs 
related to use) have been identified as key contributors to unhealthy alcohol use. 
Motivations for drinking have also helped in understanding the pathways to 
unhealthy drinking (Cox & Klinger, 1988). The currently accepted model identified four 
motivations for drinking that are cross-validated on an international stage, including 
alcohol use for enhancement (drinking to enhance mood), coping (drinking to suppress 
withdrawal symptoms), social (drinking as a social lubricant), and conformity (drinking 
to fit social expectations) motivations (Kuntsche, Stewart, & Cooper, 2008). The first two 
motivations can be fitted within Bronfenbrenner’s individual level; social and conformity 
motivations have been considered in the discussion of the microsystem level of the 
model. 
Both enhancement and coping have been shown to be predictive of the, “number 
of drinking occasions and the frequency of drunkenness in the last 30 days” (Kuntsche & 
Kuntsche, 2009). Unlike those who have drunk to address/relieve negative affect (coping 
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motives), those with enhancement motives hold a connection between alcohol use and 
rewards, often including positive emotional states. Beliefs associated with enhancement 
motivation (i.e., “drinking makes me happy”) have predicted greater positive outcomes 
associated with alcohol use. In addition, individuals who have tended towards impulsivity 
during positive affective states (a trait known as positive urgency) have increased 
frequency of alcohol use and problematic use (Coskunpinar, Dir, & Cyders, 2013; Cyders 
et al., 2007; Cyders & Smith, 2008). Additionally, impulsive action during negative 
emotions (negative urgency) has been associated with both unhealthy and disordered 
alcohol use, consistent with coping motivations (Coskunpinar et al., 2013). Further, 
results within a college sample suggested that both enhancement and coping motivations 
interact with the traits of positive and negative urgency in the association with unhealthy 
alcohol use (M. A. Cyders et al., 2007). In other words, as unhealthy alcohol use was 
developing, drinking supported a cycle enhancing desired emotional states (positive 
reinforcement via enhancement motives) while diminishing undesirable ones (negative 
reinforcement via coping motives). Interestingly, these pathways have been empirically 
examined in great depth and thus we will consider the evidence independently. 
The trajectory for developing enhancement motivations for alcohol use begins 
with the initial experiences of use and are influenced as use continues. Using a 
longitudinal approach, Warner, White, & Johnson (2007) examined trajectories of use 
across five time points from age 12 to 31. They found that those who endorsed unhealthy 
alcohol use had higher frequency of experiencing drunkenness (subjective experience of 
being “high or drunk”) during their first use of alcohol, though there was no difference 
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between the groups in reporting a positive first use experience. This suggests that despite 
meeting an expectation of the first use being rewarding, individual outcomes of first use 
(drunkenness) predicted future problematic use. Whether these differences in 
drunkenness relate to the amount consumed during first use and/or expectations for how 
drinking would make them feel (i.e., intoxicated, dizzy, high, etc.) remains uncertain. 
However, other studies have shown that subjective reports of heightened stimulating 
effects of alcohol predict greater AUD symptomology (King et al., 2014). Jester and 
colleagues (2015), found both the first occasion of drunkenness and binge use were 
longitudinally predicted by parental alcoholism and enhancement expectancies of use 
(neither cognitive improvement nor coping expectancies were predictive). In addition, 
they found that growth in one’s enhancement expectancy was best modeled by the 
combination of fixed effects (parental alcoholism, age, and gender) and random effects of 
age at onset of use and time since onset. Therefore, the modification or growth of 
enhancement motives has signified the conjoint influence of known ‘risk factors’ and 
indicated a divergent, and potentially unhealthy, group of alcohol users. 
Changes in the way alcohol has been used to regulate emotional states, and/or to 
cope with withdrawal symptoms (coping motives) has represented another possible risk 
factor for unhealthy alcohol use development. Drinking to avoid these states has been 
traditionally known as the self-medication model (Bandura, 1969; Colder, 2001; Greeley 
& Oei, 1999). In testing this model, Colder (2001) confirmed that an emotion induction, 
viewing aversive images, led to an exacerbation of respiratory sinus arrhythmia (RSA). 
As RSA has been associated with self-regulation during emotional situations, it was not 
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surprising that the change in RSA had a modest direct impact on alcohol use for coping 
reasons. Most interestingly, Colder (2001) identified significant indirect effects such that 
stress led to drinking to cope only for individuals that experienced high reactivity to the 
emotion induction, as measured by skin conductance. Studying a parallel process, Heilig 
and colleagues (2010) examined negative affect occurring within alcohol withdrawal and 
relapse. They reported that shifts in emotional processing following alcohol use greatly 
impacts relapse potential, particularly enhanced reactivity to stressors. In both models, 
drinking related to a coping motivation was greater in those with higher emotional 
reactivity. Thus, it would be reasonable to conclude that for some individuals a conscious 
or sub-conscious activation of a “drinking to cope” belief would mediate drinking 
behavior during disruptive emotional experiences. 
Given the evidence for patterns of drinking being related to emotional regulation, 
it would follow that comorbid psychiatric diagnoses frequently co-occur in individuals 
with unhealthy alcohol use. Mounting evidence has suggested a relationship with both 
internalizing (i.e. mood and anxiety) disorders (Bell & Britton, 2014; Brière, Rohde, 
Seeley, Klein, & Lewinsohn, 2014; Holahan, Moos, Holahan, Cronkite, & Randall, 2001; 
Schneier et al., 2011; Zimmermann et al., 2003), and externalizing (i.e. conduct and 
disruptive behavior) disorders (Edwards, Gardner, Hickman, & Kendler, 2016; Farmer et 
al., 2016; King, Iacono, & McGue, 2004). Further, research has found broadly-defined, 
psychological distress (i.e., the experience of any form of emotional or behavioral 
disturbance [Hill & Angel, 2005]) and the interaction between externalizing and 
internalizing symptoms to be associated with increased alcohol use (Colder et al., 2017). 
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Indeed, latent class analyses have suggested that there are patterns of psychological 
symptoms/disorders that differentiate individuals with pathological alcohol use (Glass et 
al., 2014; Kessler, Chiu, Demler, & Walters, 2005; McCutcheon et al., 2013). For 
example, Glass and colleagues (2014) found four distinct classes within Alcohol Use 
Disorder (AUD): AUD alone, AUD + internalizing, AUD + externalizing, and AUD with 
both internalizing and externalizing disorders. A complicated dynamic has long existed in 
the development of unhealthy alcohol use, between an individual’s internal/emotional 
experience (particularly increasing psychological distress) and the way that they have 
interpreted and responded to the events occurring around them (i.e., emotional 
regulation). In a similar way, demographic variables which have defined the individual 
have been seen to influence the initiation and trajectories of alcohol use. 
Among the variety of factors that described an individual, the ones that have 
proved most influential in determining the likelihood of unhealthy alcohol use include 
sex/gender, race/ethnicity, and specific sub-components of socioeconomic status (SES; 
i.e., educational attainment). As of 2015, adult men in the U.S. were identified to have a 
prevalence of AUD nearly twice that of women, 9.8 and 5.3 million, respectively 
(NSDUH, 2016). Clear biological differences have existed between the sexes in the 
processing of alcohol (e.g., males able to consume greater quantities with fewer physical 
consequences), and this certainly has contributed to the increased likelihood of alcohol 
use problems among males (Grant, Goldstein, Saha, Chou, Jung, Zhang, Pickering, Ruan, 
Smith, Huang, & Hasin, 2015; Nolen-Hoeksema, 2004). In addition to metabolic 
differences between males and females, differences have been found in the rates of 
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associated psychological and behavioral patterns (including impulsive personality [Dick 
et al., 2010; Kaiser et al., 2016; Mitchell, 2011; Nolen-Hoeksema, 2004; Stautz & 
Cooper, 2013], impulse control disorders [Ernst et al., 2006; King et al., 2004; Sartor, 
Lynskey, Heath, Jacob, & True, 2007], and use of other substances [Grant et al., 2015; 
Hasin, Stinson, Ogburn, & Grant, 2007]). 
While the gender gap has remained large, cohort studies have revealed the 
difference to be shrinking, with women’s patterns of unhealthy use showing increases 
over time (Keyes, Li, & Hasin, 2011; Keyes & Grant, 2008). In their review of the 
literature, Keyes et al. (2011) identified several possible explanations for the changing 
gender gap. These have included changes in the economic and workplace setting 
following the 1970s, greater financial independence for females, and changes in gender 
norms and values surrounding alcohol use which has resulted in more permissiveness 
attitudes (Keyes et al., 2011). Lyons & Willott (2008) began a conversation to examine 
how women understood increases in drinking among females. Before discussing their 
findings, it should be recognized that many have suggested that the influence on drinking 
behaviors has more to do with gendered behaviors, e.g., aggression and dominance, 
rather than biological sex. In support of this notion, Visser & Smith (2007) found that 
among young men masculine identity has been uniquely associated with alcohol use 
patterns. Specifically, high levels of alcohol consumption (particularly beer drinking) was 
commonly associated with masculinity, which was equivalent to other forms of 
masculinized behaviors (i.e., sports performance, sexual competence, etc.). Further 
examinations of masculinity, by Clinkinbeard and Barnum (2017) found that the specific 
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gendered trait of Dominance Masculinity (e.g., being aggressive and forceful) was linked 
with more frequent binge drinking and negative consequences regardless of gender 
identity. Lyons & Willott (2008) similarly found that drinking among women required a 
fine balance between reinventing dominance masculinity while holding onto traditional 
feminine roles (e.g., drinking in groups, sending drunk women home, and maintaining the 
caregiver role). As such, Likis-werle and Borders' (2017) examination of a small sample 
of women found that high risk drinkers were more likely to hold values of being both a 
powerful woman and feminine. 
Further, Clinkinbeard and Barnum (2017) found that holding gendered self- 
concepts that opposed the individual’s gender identity (i.e., a man with traditionally 
feminine beliefs or female with non-dominant masculine beliefs) was protective against 
the consequences of alcohol use. The same protective effects were found among young 
men with beliefs associating masculinity to rationality, health, integrity, free thought, 
resisting social pressure, and religious beliefs (Visser & Smith, 2007). As such, the risk 
for having initiated alcohol use and developed problematic patterns of use may not only 
be impacted by explicit biological contributions but also by societal (or sub-group) 
beliefs regarding the use of alcohol to establish a dominant masculine identity. Therefore, 
while male gender has been associated with greater drinking problems, sociocultural 
influences likely contribute to the changing risk for unhealthy alcohol use regardless of 
gender identity. 
Race and ethnicity have also been associated with differences in the initiation of 
alcohol use and patterns of early use. This could be related to biological differences 
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between racial groups, including differences in the functionality of enzymes that break 
down alcohol into its component parts, i.e. alcohol dehydrogenase (ADH) and aldehyde 
dehydrogenase (ALDH). The presence of the ADH1B*2, ADH1B*3 and ALDH2*2 
genes have been indicated to be protective against the progression towards alcohol related 
problems, particularly within individuals of Asian and perhaps African decent (Crabb, 
Matsumoto, Chang, & You, 2004; Wall, Luczak, & Hiller-Sturmhofel, 2016). The rate of 
aldehyde production from alcohol (completed by ADH) and subsequent elimination rate 
of aldehyde (by ALDH) could impact the likelihood of developing use related problems; 
a pathway that can be strongly impacted by the ALDH deficiency seen in ALDH2*2 
homozygotes. However, the relative protection provided by being heterozygous for 
ALDH2*2 has been suggested to also be impacted by sociocultural changes in alcohol 
use (Higuchi et al., 1994). Indeed, Wall and colleagues (2016) have reported multiple 
individual and community factors that have directly or indirectly impacted the protective 
effects of the ALDH2*2 & ADH1B*2 genotypes. These have included: ethnicity 
(primarily across Asian ethnic groups), behavioral control, childhood adversity, family 
environment, culture, and religion. Therefore, it has been suggested that the genotypic 
variation across racial groups as well as environmental differences contribute to the 
trajectory of alcohol use. Notably, acculturation into American society of individuals 
from both Asian (Wall et al., 2016) and Hispanic decent (Wahl & Eitle, 2010) has been 
associated with an increase in alcohol use, binge drinking, and alcohol related problems. 
It has also been observed that the likelihood of past month and lifetime use of 
alcohol differs between racial/ethnic groups within the United States. Hispanic 
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adolescents were found to be more likely and Asian adolescents less likely to have drunk 
a full alcoholic beverage compared to Caucasian and African American adolescents while 
controlling for grade, sex and family structure (Shih et al., 2010). These patterns of use 
were determined to be moderated by differences in individual, family and peer 
influences, which would suggest that use can be impacted by a wider socio-cultural belief 
which was tied to racial/ethnic differences. 
Finally, individuals are defined by their status within society which has been 
globally defined as SES; however, the sub-components of SES have clearly described 
variables at Bronfenbrenner’s individual level. Variables that have been used to describe 
SES include occupational status, educational attainment, and income levels. Casswell et 
al. (2003) followed a group of New Zealand young adults from 18 to 26 years and found 
that the frequency of alcohol use was only significantly impacted by income levels (both 
occupation and education were non-significant), with higher income associated with 
more occasions of use. In contrast, Barr and colleagues (2016) recently validated a causal 
relationship between educational attainment and alcohol use frequency/intoxication 
within a cohort of Finnish twins (12-26 years old). The results found educational 
attainment moderated individual environmental factors such that those with increased 
education were less impacted by their individual environment (controlling for shared 
environment and genetic components). The authors further suggested these findings were 
likely conservative when considering samples in the United States (Barr et al., 2016). 
When considering an individual’s quantity of use, educational attainment was the only 
sub-component found to be significant, with greater education predicting lower levels of 
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use (Casswell et al., 2003). Finally, when considering women in particular, 
unemployment and low SES were associated with more frequent use throughout young 
adulthood and greater amounts of use until age 26 at which point use sharply declined 
(Caswell et al., 2003). As can be surmised from these results, a need for clarity has 
remained in the determination of the effect of sub-components of SES on the initiation of 
use. Further, all of the above individual elements are likely to have been influenced by 





Looking beyond the internal experiences of the individual, Bronfenbrenner’s 
second level – the microsystem – led to consideration of the impact an individual’s 
immediate environment throughout development on alcohol use. Research has strongly 
supported the impact of an individual’s family history of alcohol dependence on the 
development of use-related problems (Beseler, Aharonovich, Keyes, & Hasin, 2008; 
Warner et al., 2007). Indeed, family history has been shown to contribute to unhealthy 
alcohol use via biological (genetic and neurological) and psychological (modeling of 
norms and expectations for alcohol use) mechanisms (Beseler et al., 2008; Kuperman et 
al., 2013). Because of the limitations of the current dataset (lacking biological predictors), 
this paper has been focused on the influence the environment has on the individuals’ 
psychological development. This narrowed lens more closely approximated the factors 
assessed within the Day One outpatient treatment setting. 
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Nash, McQueen, & Bray (2005) examined the longitudinal impact of a positive 
family environment (as measured by parental attention, monitoring and communication) 
on adolescent alcohol use. Families with a positive environment and strong parental 
disapproval for alcohol predicted less frequent teen alcohol use, as well as lower alcohol 
consumption and fewer alcohol related problems. In addition, in comparison to 
adolescents of parents with low or no disapproval, strongly disapproving families 
showed, “more positive family environments (acceptance, monitoring, and 
communication), greater self- efficacy for avoiding alcohol use, fewer peers and friends 
that drank alcohol, less approval for alcohol use among close friends, and less alcohol use 
and associated problems” (Nash et al., 2005). The work of Nash and colleagues (2005) 
suggested a supportive environment to be generally beneficial; explicitly expressed 
parental attitudes played an important role in reducing alcohol use. In fact, Campbell & 
Oei (2010) proposed that both parental behaviors and stated pro-alcohol beliefs (i.e., 
“Alcohol is a great way to relax after work”) had a strong influence on the child’s 
expectations for the use of alcohol, as well as their ability to resist use. Other family 
factors identified in Ryan, Jorm, & Lubman's (2010) review of longitudinal studies 
included explicitly stated disapproval, moderate discipline, parental monitoring, parent- 
child relationship quality, and parental support/involvement/communication. They found 
that these factors resulted in delayed alcohol initiation or decreased alcohol use in 
adolescents. Further, they determined that parental modeling of drinking behaviors (e.g., 
normalization of alcohol use via modeling of use) resulted in earlier initiation of alcohol 
use, a finding supported by Merline and colleagues’ (2008) examination of the 
28  
Monitoring the Future study. It is useful to identify that, though a limited subset of these 
parental behaviors have been specifically related to alcohol, a large majority have shown 
protective effects shared with overall risk for negative outcomes (Smokowski, Bacallao, 
Cotter, & Evans, 2014; Vassallo, Edwards, Renda, & Olsson, 2014; Yap, Pilkington, 
Ryan, Kelly, & Jorm, 2014). 
In addition to the influence of parents, peers have been found to strongly impact 
both the initiation and continuation of use, even with problematic outcomes. Nash and 
colleagues (2005) identified that nearly half of the variability in alcohol use in 
adolescents was predicted by the influence of an adolescent’s peer-groups. The effect was 
moderated by positive family environment which in turn was affected by parental alcohol 
expectations (reviewed above). A large body of research has shown that deviant 
behaviors occurring within a peer group (e.g., truancy, theft, and property damage) 
increased the likelihood of initiation, the amount of, and problems associated with 
alcohol use (Merline et al., 2008). Further, research demonstrated that something broader 
than the deviant acts or the presence of deviant others has influenced alcohol use; positive 
beliefs about alcohol use within their peer group(s) – social motivations – strongly 
contributed to an individual’s drinking (Merline et al., 2008). 
While striking consistency in drinking behavior has been seen within peer groups, 
the mechanisms by which this occurs have been debated among experts of Social 
Learning Theory. Drinking attitudes and behavior could have been directly modified by 
peer influence through modeling, imitation and reinforcement (i.e. socialization model). 
Alternatively, adolescents could have selected peers on the basis of similarities in beliefs 
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and behaviors that become mutually reinforced over time (the selection model: Bandura, 
1977). The work of D’Amico & McCarthy (2006) has shown that selection may be a 
potent factor early in development, with middle school youth being influenced by the 
perception of their peers’ beliefs surrounding alcohol use. Results have suggested 
adolescents were more likely to initiate and maintain alcohol use even if they wrongly 
believe that peers hold a positive view of alcohol use (D’Amico & McCarthy, 2006). A 
longitudinal study (Trucco, Colder, & Wieczorek, 2011) showed that perceptions of use 
had an effect on the initiation of alcohol use which strengthened across time points. This 
would suggest that peer-initiated beliefs developed and became reinforced throughout the 
period of adolescence. The socialization model has also been supported from the 
perspective of an individual’s motivations for the use of alcohol. As shown by Kuntsche 
& Kuntsche (2009), significant relationship have been found between social drinking 
motivations and alcohol use, including drunkenness. In addition, Cheetham and 
colleagues (2010) have argued for an overlap between use for enhancement and social 
motives as these components co-occur during occasions of celebration (i.e., parties, 
holidays, etc.). Unfortunately, it has remained unclear whether the perception of other’s 
alcohol use directly influences an individual’s internal motivations (enhancement, 
coping, social or conformity) or acts through an alternative mechanism for initiating, 
maintaining, or increasing alcohol use. Though no concrete pathways have been 
established, Newton, Barrett, Swaffield, and Teesson (2014) found that a reduction in 
awareness of the consequences of deviant acts and a reduced ability to say no to peers, 
resulted in greater alcohol use over a period of 18 months. Thus, an interaction between 
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social acceptability and enhancement expectancies of use was necessary to lead to 
unhealthy use. Taken together, at the microsystem levels variables including family 
environment, parental beliefs and behaviors, and peer beliefs and behaviors have been 
related to an adolescent’s drinking behavior and outcomes. 
 
 
MESOSYSTEMS & MACROSYSTEMS 
 
The final two levels of the Bronfenbrenner model were used to examine how a 
person’s community and broader societal influences impact drinking behavior. Factors 
included from the mesosystem and macrosystem address areas such as community 
structure (e.g., ease of access to alcohol within the community [Nargiso, Friend, & 
Florin, 2013]) and socioeconomic status (SES). In addition, differential cultural 
expectations surrounding alcohol use (“drinking cultures”) have been shown to vary 
across national samples (e.g., Argentina, Mexico, Poland and the United States [Borges et 
al., 2010]). As a number of these factors are regularly utilized within current studies 
(particularly the examination of mediation and moderation based on SES), a general 
overview of broadly contributing factors, as well as differential effects across groups, 
have been presented. 
The relationship with alcohol use can be communicated by a community in many 
ways, including passive communications. Community norms have been reflected to the 
individual through the accessibility and location of alcohol retailers, as well as the 
perceived permissibility of alcohol use (via modeling, direct communication or indirect 
communication [e.g., advertising] of appropriate use behavior) (Ahern, Galea, Hubbard, 
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Midanik, & Syme, 2008; Nargiso et al., 2013; Sudhinaraset et al., 2016). Some 
researchers have suggested that the density of alcohol outlets contributes to use 
independently (Ahern, Margerison-zilko, Hubbard, & Galea, 2013), while others have 
claimed that specific aspects of the community influence risk, particularly the structural 
conditions of the neighborhood (Sudhinaraset et al., 2016). Observed dilapidation, dis- 
repair, and unresponsiveness within the community, has been termed ‘neighborhood 
disorder’. It has been identified as a stressor associated with greater prevalence of alcohol 
use (Hill and Angel 2005). Duprey, Oshri, and Caughy (2017) found that neighborhood 
disorder moderated the relationship between early childhood maltreatment and late 
adolescence substance use via psychological distress. They examined moderated 
mediation (neighborhood disorder X internalizing symptoms) and found highly 
internalizing adolescents were more likely to engage in some form of substance use 
(alcohol, marijuana or cigarettes) when their neighborhood was less disordered. As other 
researchers (Hill & Angel, 2005) have found increased use among individuals with 
externalizing disorders, the impact of neighborhood disorder may depend on the 
expression of distress (presentation of internalizing or externalizing symptomology). 
Jitnarin and colleagues' (2015) closer examination of neighborhood disorder identified 
that it could represent a marker of social disadvantage, particularly for Midwestern men. 
Together neighborhood disorder, the density of alcohol outlets, and perceived community 
permissiveness have created social expectations both about alcohol use behaviors and 
about the social advantages and disadvantages of group membership (i.e. identifying with 
the community of drinkers). 
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Similar to the broad influence of the community, socioeconomic status (SES) has 
been assumed to impact the likelihood of developing unhealthy alcohol use. The field 
remains in debate regarding whether SES has a significant impact on the frequency and 
quantity of alcohol use (Bonevski, Regan, Paul, & Baker, 2014; Intarut & Pukdeesamai, 
2017; Lee et al., 2015; Patrick, Wightman, Schoeni, & Schulenberg, 2012; Wiles et al., 
2007). More recent research has focused on determining relationships between alcohol 
use and components of SES, including occupational status, educational attainment, and 
income levels. As described in the individual section, even these sub-components of SES 
have been suggested to influence differential patterns of alcohol use that pertain to the 
socioeconomic status of an individual, particularly their income and educational 
attainment. 
Finally, unexplained patterns of use would suggest a wider socio-cultural belief. 
 
Though a commonly held societal or cultural alcohol use belief has been difficult to 
quantify, inherent differences in drinking cultures have been documented, even among 
countries in the European Union (Gordon, Heim, & MacAskill, 2012). For example, 
Gordan and colleagues (2012) suggested the overall contribution to differences in 
problematic drinking cultures – between France, Germany, Sweden, Spain, and the 
United Kingdom – may be marked by three factors. These factors were: 1) the degree of 
hedonism (regularity and extent of use for the pursuit of pleasure), 2) the general function 
(social, ritual, enhancement, coping), and 3) the degree of social controls which surround 
alcohol use. More research, utilizing longitudinal and/or development frameworks, has 
been called for in order to understand these larger cultural influences on the initiation and 
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development of unhealthy alcohol use. The current work has suggested global influences 
 
– including community influences, sub-components of SES, and drinking culture – to 





As reviewed above, research supported a complex and interacting web of 
psychological and sociological factors which contributed to unhealthy alcohol use. The 
Bronfenbrenner model provided a useful framework, both to group predictors of alcohol 
use and to posit the way these factors influenced the development of patterns of 
unhealthy alcohol use. The differential trajectories of alcohol use appeared to be 
influenced by an individual’s immediate response to alcohol, their level of psychological 
distress and their beliefs in alcohol’s ability to modify their current (generally emotion- 
related) experience. Further, the initiation of use was found to be influenced by individual 
differences in sex/gender, racial/ethnic group, acculturation status, and components of 
SES such as income-level and educational attainment. Many of these individual variables 
were also influenced by the environment within which the person develops, primarily via 
sociological factors. Most notably, family members and peers demonstrated marked 
influence on the development of beliefs about the permissibility and motivations for 
alcohol use. The inherent instructions about the permissibility of alcohol use were further 
impacted at the level of an individual’s community. The differential trajectories in use 
behaviors caused by neighborhood disorder and mediated by psychological distress 
provided an excellent example of a communities’ influence. Finally, the most diffuse 
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factors on an individual’s alcohol use behaviors were those related to societal 
expectations, including SES, acculturation, and drinking cultures. Together each of 
Bronfenbrenner’s levels identified a cascade of risk factors that influence both the 
likelihood of initiating alcohol use and the development of unhealthy use. Given the 
longitudinal effects of the factors reviewed, we have examined the influence of these 
factors on an individual’s treatment outcomes, when they engage in outpatient treatments 
for unhealthy alcohol use. 
 
 
Treatment of Unhealthy Alcohol Use 
 
In order to examine predictors of treatment effectiveness, we have presented 
content such that current treatments for unhealthy alcohol use and how people access 
these treatments was understood. Since the late 80s, there has been an increased focus on 
supporting individuals in accessing effective treatments. A summary of the research by 
Bien, Miller, & Tonigan (1993) identified that utilization of brief interventions (e.g., 
identification of a problem, advice for remission, and follow-up) was generally effective 
across drinkers of different levels of severity and racial/ethnic groups. However, they also 
noted that individual characteristics contributed to differential success in treatment. As a 
result, the matching hypothesis was introduced (Donovan & Mattson, 1994; M. E. 
Mattson, 1994). This identified that individualized characteristics (gender, alcohol use 
severity, etc.) would be predictive of the effectiveness of a particular format of treatment 
relative to others, e.g., Bien and colleagues (1993) study of gender. This led to Project 
MATCH, one of the largest nationally funded studies ever conducted (fully described in 
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Barbor & Del Boca, 2002). As mentioned previously in this literature review, Project 
MATCH examined differential treatment effectiveness as predicted by ten client 
characteristics (severity of alcohol involvement, cognitive impairment, client conceptual 
level, gender, meaning seeking, motivational readiness to change, psychiatric severity, 
social support for drinking versus abstinence, sociopathy, and typology). The effects of 
these predictors were examined within two separate setting arms (outpatient and 
inpatient/aftercare) with three treatment types: Cognitive Behavioral Therapy (CBT), 
Motivational Enhancement Therapy (MET), and Twelve-Step Facilitation Therapy 
(TSF). 
The Project MATCH Research Group’s study showed a general benefit of 
treatment within both setting arms and limited differences between any of the treatment 
types, despite validation of treatment integrity (Allen et al., 1997; Connors et al., 1998). 
However, Allen and colleagues (1997) found several interesting interaction effects 
between the treatment setting and either: (1) treatment type (TSF showing slight 
advantages in the outpatient setting) or (2) individual character predictors (complex 
influences of meaning seeking, typology, psychiatric severity and motivation depending 
on setting, treatment type and duration of treatment). Retrospective analyses have 
identified additional differences between groups, including slight racial differences in 
frequency of drinking (black clients less frequently than white, but not Hispanic, clients 
[Tonigan, 2003]) and participant self-selection effects on treatment outcome (those 
attending a single session had worse initial and outcome data than either full 12-week or 
zero week attendance [Cutler & Fishbain, 2005]). Although attempts to identify more 
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effective treatment models have yielded similarly inconclusive results, consistencies have 
appeared across treatments which has supported the current level of effectiveness (Imel, 
Wampold, Miller, & Fleming, 2008). These commonalities focus on the benefits of 
therapeutic alliance, specific therapeutic skills and eliciting change talk from the client, 
across therapeutic treatment formats for unhealthy alcohol use (Feldstein Ewing, Filbey, 
Sabbineni, Chandler, & Hutchison, 2011; Magill et al., 2016; Morgenstern et al., 2012). 
In other words, it matters more that patients have engaged in treatment in a way that 
encourages continued self-examination of recovery from use. 
Though the literature has grown, including emphases on personalized medicine 
(Litten et al., 2015), many of the theoretically supported models have yet to be 
implemented within the outpatient treatment setting. McLellan and Meyers (2004) found 
that 90% of specialty treatments focus on models of treatment that have shown limited 
effectiveness. In response to ongoing limitations in treatment, several groups have 
identified the need to describe the advances in research within a conceptual framework 
that integrates psychological and social factors that could be applied across treatment 
settings. Thus, the remainder of this literature review has been targeted towards two 
goals: 1) having examined the evidence surrounding the effect of psychosocial predictors 
on treatment outcome, via the utilization of the Bronfenbrenner model, and 2) having 
considered the structural relationship between variables in order to develop a testable 
model of each individual’s pathway to recovery from use. 
 
 
Psychological and Sociological Predictors of Treatment Outcome 
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Barriers to Treatment Engagement 
 
Prior to having reviewed the factors predicting treatment outcome, we recognized 
that the whole population of individuals with unhealthy alcohol use would not be 
represented within the literature. This was because some patients experience barriers 
while initiating treatment. Storbjork and Room (2007) reported two distinct types of 
unhealthy alcohol users: treatment-seeking individuals with heightened severity of 
alcohol use (tending to be middle-aged males with complicated functional and/or 
psychological impairments) and treatment-avoidant individuals with moderate to mild 
unhealthy use. Descriptive categories of treatment engagement have failed to define why, 
for what nuanced reason(s), individuals have opted out of treatment for unhealthy 
patterns of alcohol use. After completing a qualitative study in unhealthy drinkers 
(measured by AUDIT-C and 3+ dependence criteria), Wallhed Finn, Bakshi, and 
Andréasson (2014) reported three primary barriers to treatment engagement: felt 
stigmatization, held beliefs of independently gained success (i.e., precontemplation, 
denial or overconfidence), and held uncertainties surrounding treatment. 
The internal experience of ambivalence has been influenced by stigma, both in the 
decision-making process and engagement in treatment for alcohol use. The experience of 
stigma (i.e. labels such as “the socially-deprived alcoholic”) was negatively related to an 
individual’s engagement in treatment, particularly among males, individuals with low 
SES (education and income, specifically), and certain racial/ethnic groups (Keyes et al., 
2010; Wallhed Finn et al., 2014). Other identified barriers included resistance to having 
alcohol use labeled as a problem and difficulty in the process of building confidence to 
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make a change in use independently. Though Bishop (2018) demonstrated a marked 
ability for unhealthy users to engage in change independently (~11% have lifelong use), 
the 16 year half-life of alcohol dependence suggested that, “addiction [was] ambivalent 
drug use, which eventually involve[d] more costs than benefits (otherwise why quit?)” 
(Heyman, 2013). This idea paralleled the redefinition of unhealthy alcohol use as both 
compulsive (e.g., influenced by urges to use) and susceptible to changes in processing 
(i.e., motivated beliefs, self-deception, and cognitive deficits) of the incentives available 
within the environment (Henden, Melberg, & Røgeberg, 2013; Pickard, 2016). Finally, 
non-treatment seekers were clear that, were they to engage in treatment, two primary 
aspects would have been essential (Keyes et al., 2010): confidence in the care provider 
(experience, expertise, supportiveness) and attractiveness of treatment (easy access, high 
autonomy, maintenance of daily life). Though potential patients were certain that 
treatment could support identifying the “underlying reasons [for use] that have to be dealt 
with,” many were genuinely uninformed of the expectations, options for, and content of 
treatment (Wallhed Finn et al., 2014). As such, the experience of barriers within any of 
these content areas (and likely others) has contributed to the experience of real or 
imagined barriers to change and thus impacted the patients ability to have engaged in or 
maintained treatment (Cutler & Fishbain, 2005). 
INDIVIDUAL 
 
To understand factors affecting treatment, it was useful to reflect on factors that 
impacted the initiation of use (reviewed above). Some of the strongest influences were 
drinking motivations and factors that reinforced drinking behavior. As such, this paper 
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first focused on the utilization of positive forms of motivation for recovery from use. 
Given the high rate of treatment failure, and the nature of being immediately rewarded by 
alcohol consumption, financial contingencies have been one strategy for enhanced 
motivation and improved treatment outcomes. Petry, Martin, Cooney, and Kranzler 
(2000) found that utilizing financial reinforcement for confirmed abstinence (negative 
breathalyzers) was effective for improving treatment engagement and outcomes over an 
8-week course, when compared to treatment as usual. The long-term effectiveness of this 
approach has not been determined. Similarly, motivational enhancement/interviewing 
approaches have been shown to be effective by identifying and bolstering an individual’s 
motivations and readiness for change in use, i.e. motivational readiness (Ilgen, McKellar, 
Moos, & Finney, 2006; Miller & Rollnick, 2002). The concept of motivation for change 
was strongly influenced by the Stages of Change model (DiClemente & Prochaska, 
1998). Though clinically interpreted as a fluid transition through the stages of 
precontemplation, contemplation, action, and maintenance, research has continued to 
question the best model of the process of recovery (Littell & Girvin, 2002; Zemore & 
Ajzen, 2014). Very early on, Diclemente and Hughes (1990) identified that these 
categories were important markers of a balance between an individual’s confidence in 
their ability to change (self-efficacy) and concern for the risk of relapse (temptation). 
This would suggest motivational readiness (assessed by stages or continuously) 
represented a balance between supporting confidence in change, as well as identifying 
and countering the reasons for relapse, an area of research heavily contributed to by 
Marlatt (1996). Together these results suggested that positive reinforcement was essential 
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in beginning the process of modifying drinking behaviors (particularly an internal sense 
of motivational readiness). 
Among individuals beginning to decrease or quit alcohol use, Zywiak, Connors, 
Maisto and Westerberg (1996) identified positive affect/social factors as one of three 
primary triggers of relapse (also negative affect and degree of withdrawal/desire to 
drink). The results of their study indicated that males may be more likely to experience 
challenges in recovery from use for positive affect/social reasons, such as “I was with 
others having a good time and we felt like getting drunk together” (Zywiak et al., 1996). 
However, many studies have either not reported the relationships between 
drinking/relapse motives (Canale, Vieno, Santinello, Chieco, & Andriolo, 2015) or found 
no relationship between positive affect/social motives and treatment outcomes (Elliott, 
Aharonovich, O’Leary, Wainberg, & Hasin, 2014). Further, the related behavioral 
predictor of positive urgency (engaging in impulsive acts during the experience of 
heightened positive emotions) has not been shown to relate to differences in treatment 
outcomes or to be indirectly impacted by treatment (Hershberger, Um, & Cyders, 2017). 
Thus, the influence of positive emotional experiences on recovery from use has remained 
debatable and may ultimately have little impact on the outcome of treatment. 
On the other side of the equation, the effects of negative reinforcement were 
found to contribute to continued engagement in patterns of unhealthy alcohol use via 
reduced withdrawal symptoms, including associated negative affect, and the completion 
of relapse behaviors (Baker et al., 2004; Breese et al., 2011; Cheetham et al., 2010; Fox et 
al., 2007; Robinson & Berridge, 2003; Ryan, 2002; Sher et al., 2005). Indeed, Zywiak 
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and colleagues (1996) found that negative affect was a primary reason for relapsing to 
unhealthy alcohol use, and led to greater amounts of use and longer duration of relapse, 
particularly among women. Following a 60-day motivational intervention, drinking to 
cope with negative affect was shown to relate to the amount of alcohol consumed per 
drinking day and likelihood of meeting criteria for alcohol dependence (Elliott et al., 
2014). These results would suggest a stable trait influencing alcohol use behaviors. 
Treatments have been developed that target negative affect in order to reduce the 
impact on recovery from use. Anker, Kushner, Thuras, Menk, and Unruh (2016) utilized 
Cognitive Behavioral Therapy techniques (psychoeducation, cognitive restructuring and 
coping during a stress-inducing imaginal exposure) which supported patients with 
heightened baseline emotionality in reducing alcohol use at a four-month follow-up. A 
pilot study which added Affect Regulation Training, led to significant benefits over CBT 
alone (Gulliver, Gudleski, & Bole, 2014). Notably, patients were significantly more 
satisfied by the combined treatment which may also enhance treatment retention. Further, 
longitudinal studies of individuals who attended Alcoholics Anonymous have shown 
enhanced coping with emotional states to be associated with the duration of participation. 
Interestingly, this effect was mediated through a reduction in impulsivity, particularly in 
adults less than 25.4 years of age (Blonigen et al., 2011, 2013). 
Naturally, these results have led researchers to examine factors underlying 
recovery from unhealthy alcohol use, particularly if ability to cope with emotion or 
retrain impulsive tendencies influenced outcome. In order to examine this question, 
Maisto and colleauges (2017) studied both the trait-like and situational factors that 
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contribute to the occurrence and degree of a relapse in alcohol use. They found that the 
trait-like, cumulative impacts of greater reactivity to social challenges (as measured by 
systolic blood pressure) and situational feelings of stress (measured by daily electronic 
momentary assessment) both contribute to the occurrence and amount drunk during a 
relapse (Maisto et al., 2017). These results paralleled the finding that negative urgency, 
which integrates both trait reactivity within states of negative affect, interfered with 
treatment outcomes and decreased only a limited amount during treatment (Hershberger 
et al., 2017). The integration of these studies has supported a vital role of negative affect 
in recovery from use with more concrete roles of individual variability in ability to 
tolerate negative emotional states and engage in non-impulsive responses. Interestingly, 
some studies have suggested a moderating effect of demographic variables for ability to 
evoke change in each of these factors as therapeutic targets, female gender and younger 
age, respectively. 
An individual’s experience of serious mental health symptoms was another 
perceived barrier to making a change in patterns of alcohol use (McCallum, Mikocka- 
Walus, Gaughwin, Andrews, & Turnbull, 2016). Surprisingly, within a nationally 
representative sample (Epidemiological Catchment Area study), the presence of 
comorbidity (i.e., more than one clinical diagnosis) occurred in nearly half (47%) of those 
meeting criteria for an alcohol use disorder (Helzer & Pryzbeck, 1988). Other studies 
have suggested that the occurrence of a comorbidity may range from .14 to .75 (Burns et 
al., 2005; Mellentin, Nielsen, Stenager, & Nielsen, 2015; Schuckit et al., 1997). Johnson, 
Cloninger, Roache, Bordnick, and Ruiz (2000) compared sub-groups based on the age of 
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onset within a sample of outpatient treatment seeking patients; they found a heightened 
level of psychological and social distress within individuals who initiated alcohol use 
prior to 20 years of age (relative to onset after 25 years old). Though they determined age 
of onset not to be a reliable indicator of homogeneity among those with unhealthy alcohol 
use, it has provided insight into possible ‘types’ of drinking groups. Regardless, 
comorbid mental health problems are associated with greater severity of alcohol use 
behaviors (Burns et al., 2005; Glass et al., 2014; Kaufmann, Chen, Crum, & Mojtabai, 
2014; Mellentin et al., 2015; Newton-Howes et al., 2017). Though there are 
contradictions to the impact of psychological severity (Maisto et al., 2017), the 
consideration of differential trajectories based on the class of psychological distress (i.e., 
internalizing, externalizing, combined) has provided even greater clarity. 
First, the influence of co-occurring internalizing disorders was examined with the 
most common disorders being mood and anxiety (major depression, dysthymia, and bi- 
polar; generalized anxiety, social anxiety and agoraphobia: Burns et al., 2005; Glass et 
al., 2014). Within studies of individuals with comorbid anxiety and/or depression, general 
themes have included increased baseline severity of alcohol use, both frequency and 
amount, as well as equivalent recovery from use with moderate to large effects of 
treatment (effect sized ranged from 0.58 to 1.35: Burns et al., 2005; Kaufmann et al., 
2014; Mellentin et al., 2015). Of interest, past reports indicated the occurrence of 
comorbidity was more common in women (65% versus 44% in men), particularly for a 
co-occurring anxiety or depression diagnosis (Helzer & Pryzbeck, 1988). Individuals 
with comorbid depression/anxiety utilized services as much (Mellentin et al., 2015), if 
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not more frequently (Kaufmann et al., 2014) when compared to individuals with 
unhealthy alcohol use alone. Despite also reporting similar treatment satisfaction, 
Kaufmann and colleagues (2014) found that individuals with comorbid anxiety or 
depression were more likely to have an unmet need for treatment and greater number of 
barriers to treatment, particularly attitudinal and financial. Of note, discussion of specific 
internalizing diagnoses should be considered preliminary as nuances have only begun to 
be explored within sample sizes that are far too limited to provide generalizable results 
(e.g., Kushner et al., 2005). 
With this qualification, specific impacts have begun to be established dependent 
on the type of internalizing disorder. Within those individuals experiencing comorbidity 
between alcohol use and depressive disorders, Karl Mann, Hintz, and Jung (2004) found 
a lower percentage of relapse specifically among the women of this group at 12 month 
(which has also been seen within samples of mixed anxiety/depression comorbidity 
[Sánchez-Peña, Alvarez-Cotoli, & Rodríguez-Solano, 2012]). When researchers 
compared three groups of individuals based on maintenance of abstinence through 
treatment (early relapse vs. late relapse vs. abstainers), it was found that those with 
comorbid anxiety disorders (particularly social anxiety and agoraphobia) were more 
likely to be in the early relapse group (Schellekens, de Jong, Buitelaar, & Verkes, 2015). 
Further, the examination of two-month follow-up data indicated that the presence of an 
anxiety disorder was predictive of increased risk for persistence of alcohol use, 
particularly for social anxiety and panic/agoraphobia, but not for those with depressive 
disorders (Kushner et al., 2005). Schellekens and colleagues (2015) attributed this 
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difference to increased craving among those with comorbid alcohol use and anxiety, 
which has been supported by previous research (Johnston, Thevos, Randall, & Anton, 
1991). Therefore, even within the internalizing disorders, differences in the trajectory of 
recovery from use were apparent, with individuals experiencing comorbid anxiety (and 
perhaps specifically interpersonally avoidant disorders such as social anxiety and 
agoraphobia) had increased likelihood of relapse when compared to those with co- 
occurring depression. 
As described above, those individuals who have experienced comorbid 
externalizing disorders were also noted to modify the trajectory of recovery, of which 
antisocial personality disorder (ASPD) and co-morbid substance use have been most 
frequently documented (Glass et al., 2014; Grant, Goldstein, Saha, Chou, Jung, Zhang, 
Pickering, Ruan, Smith, Huang, Hasin, et al., 2015; Helzer & Pryzbeck, 1988). The 
prevalence of ASPD co-occurrence with unhealthy alcohol use ranged from 15-41%. It 
has been associated with earlier age of onset of alcohol use, greater legal/physical/social 
problems, more concurrent substance use, less likelihood of speaking to a provider about 
the occurrence of unhealthy alcohol use, and greater alcohol use at treatment onset 
(Helzer & Pryzbeck, 1988; Newton-Howes et al., 2017). Through meta-analysis of the 
impact of comorbid personality disorders on treatment for unhealthy alcohol use, 
Newton-Howes et al. (2017) determined relapse and retention issues to be more of an 
issue when compared to patients with a personality disorder. However, the amount and 
frequency of alcohol use showed similar changes between these groups, despite greater 
frequency of use at baseline for the personality disorder group. Researchers noted an 
46  
overall low quality of data within the utilized studies, particularly in the use of treatment 
completer analyses which they noted as a potential source of bias for the results (Newton- 
Howes et al., 2017). 
The prevalence rates for comorbid substance use were found to vary widely 
between studies, which could reflect differences in the substance focused on and the 
demographics of the sample, particularly age, race/ethnicity, and gender (Gilder, 
Stouffer, Lau, & Ehlers, 2016; Grant et al., 2015; Malcolm, Hesselbrock, & Segal, 2006). 
Across studies, the occurrence of multiple substance use disorders (versus unhealthy 
alcohol use alone) was associated with lower education, greater frequency of drop out 
from school, greater occurrence of internalizing (major depressive episodes, panic 
disorder, and social and specific phobias) and externalizing (ASPD/CD) diagnoses, 
earlier onset of alcohol use, greater severity of alcohol problems, and – despite more 
frequent treatment attempts – less frequent recovery from unhealthy alcohol use (Gilder 
et al., 2016; Grant et al., 2015). Thus, individuals who have used multiple substances 
demonstrated greater impairment, particularly in the realm of psychological distress. 
Within a sample of Alaskan Natives, Malcolm et al. (2006) found the co-occurrence of an 
opioid use disorder predicted earlier onset, greater alcohol problems, and more severe 
withdrawal when compared to co-occurring marijuana or cocaine use disorders. 
Therefore, the class of substances could be suggested to influence the degree of 
psychological distress. Altogether, externalizing disorders were shown to impair the 
efficacy of treatment with both general (level of externalizing) and specific effects (co- 
occurring use disorders). Indeed, researchers have demonstrated that highly externalizing 
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drinkers had greater severity of unhealthy alcohol use (Colder et al., 2017; Glass et al., 
2014) and poorer treatment outcomes (Grant and colleagues (2015). However, no studies 
could be found which examined the effects (categorically or continuously) of higher 
levels of psychological distress on the treatment of unhealthy alcohol use. 
Finally, demographic characteristics of the individual have been shown to 
influence the trajectory of recovery both due to the effectiveness of treatments within a 
specific sub-population, as well as barriers to having been able to engage in treatment. 
Though there were discrepancies across analyses, Adamson and colleagues' (2009) meta- 
analysis of studies identified that gender (being female identified), employment, and 
socioeconomic status (particularly higher income) were consistently predictive of 
recovery from unhealthy alcohol use. These results were supported via the naturalistic, 
longitudinal (1, 3, 8, and 16 year) observation of a group of individuals who, at the initial 
visit, had not sought treatment despite a recognized problem with alcohol use (Moos & 
Moos, 2006). Within this study they examined differences in outcomes for those who 
sought help (professional treatment and/or self-help groups) and identified predictors of 
short-term remission (at 3 years) and long-term relapse (at 16 years). Moos and Moos 
(2006) found help seeking behaviors facilitated recovery. Regarding short-term 
remission, they found female gender and higher educational attainment were significant 
predictors. They also reported that lower educational attainment and unemployed status at 
the 3-year follow-up was predictive of individuals who experienced recurrence of alcohol 
use at year twelve (Moos & Moos, 2006). The more favorable trajectory for women in 
the treatment of alcohol use problems could be associated with other factors – discussed 
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above – which have been shown to relate to treatment outcomes such as the severity of 
baseline alcohol use (generally lower), co-occurrence of internalizing psychological 
disorders, and responsiveness to standard treatment approaches (Litt, Kadden, & Tennen, 
2015; Mann et al., 2004; McCutcheon et al., 2014). Further, a predictive model 
developed by Sugarman et al., (2013) suggested that the impact of gender on treatment- 
related drinking outcomes may be partially mediated through educational attainment. 
Altogether it would appear that females have better outcomes when engaged in a process 
of recovery. 
Unlike the clear evidence of differences based on gender, race and/ethnicity has 
impacted recovery from unhealthy alcohol use in ways that have varied widely. Though 
Adamson et al. (2009)  found no specific race/ethnicity differences in treatment 
outcomes, Priester and colleagues (2016) described numerous barriers specific to 
racial/ethnic minorities. Barriers occurred across several areas, including insurance/policy 
barriers (lack of insurance for men of color), service provision (cultural 
insensitivity/incompetence), and service availability (lack of specialized treatment or 
transportation to treatment in the community). The authors also expressed that, "societal 
oppression [could] contribute to differential, inaccurate, and under diagnosis of 
individuals who [were] racial/ethnic, gender, or sexual minorities." The influence of these 
diagnostic discrepancies could compound the experience of being dually-stigmatized 
(i.e., being a member of a group marginalized due to cultural and psychological stigmas). 
Though much can still be learned about the impact of these barriers on treatment 
engagement and completion, several studies have confirmed a marked disparity in 
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treatment utilization and outcome for black and Latino/a individuals (Guerrero, Marsh, 
Khachikian, Amaro, & Vega, 2013; Saloner, Carson, & Lê Cook, 2014). Guerrero and 
colleagues (2013) identified notable differences in the occurrence of unhealthy alcohol 
use based on region of origin, age of emigration, and level of acculturation, as well as 
differences in the demographics of individuals entering treatment. They reported that 
having "young, less-educated, and treatment-naive Latinos entering [treatment would] 
have significant implications for health literacy and intervention tolerability, fidelity, and 
acceptability.” In their examination of disparities in treatment completion across 
racial/ethnic groups, Saloner and colleagues (2014) noted that black and Hispanic youths 
experienced several individual-level protective factors (e.g., substance use history, living 
and schooling arrangements, and referral pathways). These protective factors prevented 
these groups from having experienced a widening of disparity in treatment outcomes 
when compared to white youth. It should be noted that broader influences within an 
individual’s social relationships, community and society influence each of these 
individual factors both directly and indirectly. As such, we have continued outward to 





An individual’s recovery from unhealthy alcohol use was investigated from the 
perspective of possible contributors from their social environment, including specific 
impacts of family members and the general influences of peers. An individual’s family 
history of use predicted both the initiation and trajectory of alcohol use over time. 
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Capaldi, Feingold, Kim, Yoerger, and Washburn (2013) determined that more 
widespread family history of alcohol use significantly differentiated individuals with 
high, though desisting, levels of problems associated with alcohol use. Interestingly this 
group of individuals were also likely to have high and decreasing amounts of use, which 
suggests that family history may predict a worse course of unhealthy alcohol use (Capaldi 
et al., 2013). Indeed, having a family history of alcoholism, particularly male alcoholics, 
has been associated with a younger age of onset for alcohol use (Johnson et al., 2000). 
However, as predictors of treatment effectiveness, Adamson, Sellman, and Frampton 
(2009) stated, “onset age of alcohol misuse, alcohol-related problems, and family history 
of alcohol or drug problems were all poor predictors of outcome.” Thus, these factors 
have been considered as proxy risk factors (i.e., related to but not causal of), which stood 
in for the correlated factors of greater psychosocial stressors, craving, or, most likely, 
baseline alcohol consumption (Johnson et al., 2000). Given that family history was non- 
specific, more focus has been placed on the relationship between an individual’s alcohol 
use and their family relationship. 
To capitalize on the focus on family relationships, many treatments have been 
developed that utilized an individual’s family members to support treatment. Individuals 
that have engaged in one of these models of treatment, community reinforcement (CR) 
supports (CR-Training prior to treatment or CR-Approach during treatment), were found 
to be more likely to initiate treatment, as well as greater levels of abstinence at 6-month 
and 2-year follow-ups (Edwards & Steinglass, 1995). The combination of these 
approaches in community reinforcement and family training (CRAFT) were suggested to 
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be particularly effective for individuals who have been resistant to treatment. Miller, 
Meyers, and Tonigan (1999) found that treatment resistant drinkers were significantly 
more likely to engage in treatment (assessment and at least one session) at both 6 months 
and 1 year after group randomization, when family members were trained in CRAFT 
versus Al-anon or family intervention models. As stated by Edwards & Steinglass (1995), 
“involving the spouse in the [treatment compliance] as well as providing communication 
skills training appear to be the significant components of treatment success.” Indeed, the 
experience of high social support from an individual’s social network (e.g., family and 
friends) has been shown to be predictive of longer engagement in treatment and greater 
reductions in unhealthy alcohol use (Dobkin, De Civita, Paraherakis, & Gill, 2002; 
Mavandadi, Helstrom, Sayers, & Oslin, 2015). 
Engagement in CRAFT was not always shown to be ideal, as individuals with 
limited social support were found to have significantly less effectiveness in CR, when 
compared to individual treatment (Edwards & Steinglass, 1995).Within this group, a 
standard brief informational intervention proved more advantageous for changes in 
alcohol use, notably even compared to individuals with high social support who engaged 
in standard care (Mavandadi et al., 2015). Though CR treatments assisted those with 
strong family support in becoming motivated for treatment, both the type of intervention 
and social context of the individual undergoing treatment matters in the determination of 
outcomes. 
Variability in the number of supports, types of supports (e.g., family or friends), 
and format of support (e.g., general sense of wellbeing, specific support for abstinence, or 
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specific support for alcohol use) has made the ability to fully understand the social 
context of recovery difficult (described by Groh, Jason, Davis, Olson, & Ferrari, 2007). 
When the type and form of support within a recovery model (i.e., the Oxford House) was 
more closely examined, the factors of length of stay, general friend support, and their 
interaction were found to be significant predictors of less alcohol use at follow-up. 
Indeed, it appeared that low general friend support was a risk factor for individuals that 
was mitigated after a six month stay in the recovery environment (Groh et al., 2007). This 
was supported by a naturalistic five year follow-up of a sample of at-risk drinkers that 
differentiated two separate types of recovery profiles: low-risk drinking and abstinence 
(McCutcheon et al., 2014). The low-risk group were more commonly women undergoing 
changes in roles (e.g., first child during the five-year period), generally experienced lower 
severity of unhealthy alcohol and drug use at baseline, and experienced higher general 
levels of family support. Alternatively, the abstinent group had higher baseline severity in 
unhealthy alcohol use, greater losses of relationships, and lower family support, but 
engaged in more treatment (e.g., AA and specialist therapy) and had higher general 
support from friends. Therefore, it can be deduced that the path to recovery from use may 
naturally be different for individuals who have experienced general support from family, 
as compared to general support from friends. 
Families involvement has demonstrated marked influence on a patients 
motivation for changes in alcohol use, yet the impact of friendships have remained 
unclear. Best & Lubman (2017) showed that within an adolescent sample, treatment had 
little effect on the number of friends an individual had, but a marked impact on the 
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proportion of their current friends that were using drugs or alcohol. This resulted in 
changed dynamics within their friendships and families (i.e., less conflict and overall 
social dysfunction), as well as modified behavioral patterns of substance use and criminal 
activities. Therefore, the engagement in treatment supported changes both in general 
relational engagement and specific support for abstinence within an individual’s 
friendship group. Litt, Kadden, and Tennen (2015) found that a specific treatment which 
focused on the development of a social network supportive of abstinence was beneficial 
in the process of recovery for men, but not women. Interestingly, they found that women 
generally had more currently using friends, as well as greater mental health concerns and 
lower self-efficacy, and thus were unable to expand their social network or enhance self- 
efficacy during treatment (Litt et al., 2015). Additional factors may have influenced the 
ability of patients to have engaged in re-establishing a peer network supportive of 
abstinence (e.g., gender, psychological distress or self-efficacy), but these results have 
validated the influence of both family and friend support on recovery from unhealthy 
alcohol use. Though social support was not directly assessed within the study, Best and 
Lubman's (2017) results have suggested that distress occurring within social relationships 
could be a relevant proxy risk factor relevant to the current study. 
 
 
MESOSYSTEMS & MACROSYSTEMS 
 
As the focus has shifted outwards, a sparsity of literature was notable for factors 
within an individual’s mesosystem (community) and macrosystem (social groups and 
society) which have described an influence on the outcomes of treatment for unhealthy 
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alcohol use. This area of research has been understudied, perhaps due to the difficult 
nature of controlling community and society level variables. 
At the level of the mesosystem specifically, communities have been considered 
for their influence on effectiveness of and access to treatment services. Elliott and 
colleagues (2016) were among the few who have directly examined the impact of the 
community. They found that community-wide permissibility of alcohol use influenced 
recovery from heavy use within a sample of HIV-infected adults (Elliott et al., 2016). 
Specifically, they found that motivational interviewing was more effective at reducing 
drinks per drinking day among individuals with communities that had a permissive 
attitude about drinking, as compared to an educational control (Elliott et al., 2016). The 
specificity of the study sample has limited the generalizability of the result; however, this 
study would suggest changes in the setting of treatment were more common when the 
community wasn’t already supporting changes in use. 
The majority of the available literature has examined the potential for access to 
support for individuals within a community setting, such as a sober living community. 
Mericle, Karriker-Jaffe, Gupta, Sheridan, and Polcin (2016) found that the presence of 
Sober Living Houses was associated with community demographics; however, the 
affordability of sober living was impacted by the community as well. While all facilities 
were more commonly co-located with treatment and self-help facilities, affordable 
facilities ($300-1450/month) also tended to be in areas with more unemployment and a 
greater presence of drinking venues. Though sober living houses have been shown to be 
effective (Groh et al., 2007), the specific impact on treatment outcomes, relative to these 
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differences in community setting, could not be determined. However, Mericle et al. 
(2016) found that communities with a greater proportion of Hispanic and Asian American 
individuals tended to have fewer Sober Living Houses and thus decreased access. 
Though there have not been studies which directly assessed impacts of living in a 
culturally diverse community, researchers have discussed societally-held beliefs about 
treatment engagement (see stigmatization above) and societally-influenced structural 
barriers to successful completion of treatment which are influenced by race/ethnicity. 
Indeed, Saloner and colleagues (2014) identified variables at the macrosystem level 
which led to lower rates of treatment completion for black and, particularly, Hispanic 
youth. These included fewer available services, lower financial accessibility, and greater 
concentration of minorities within the community. Further, Guerrero et al.'s (2013) found 
that, among individuals of Latino/a ethnicity, differential treatment outcomes could be 
addressed by structural modifications making treatment more responsive to the needs of 
this ethnic group. Modifications to treatment which were found to increase engagement 
and success of treatment included culturally competent treatment (e.g., language 
concordance), longer residential stays, greater co-occurring disorder training for staff, 
and participation in after-care outpatient treatment (Guerrero et al., 2013). Of course, 
these disparities in access and outcome of treatments for unhealthy alcohol may have 
resulted from interactions between factors at the level of the individual, mesosystem and 
macrosystem which have yet to be uncovered. 
Priester and colleagues (2016) identified a full range of individual (discussed 
above) and structural barriers to accessing or completing treatment. Structural barriers 
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included: poor provider training (only 10% of providers feel prepared and many are 
underqualified), limitations in service availability (wait-lists), inadequately provided 
services (provider biases and unclear best-practices), coverage issues for 
insurances/policies, racial/ethnic disparities in access/utilization of services, and under- 
identification of comorbidities (Priester et al., 2016). Even once an individual has 
accessed treatment within their community the effectiveness of treatment generally relies 
on the adequate provision of evidence-based treatments for unhealthy alcohol use. Poor 
performance could be attributed to both the experience and interpretation of clinical 
indicators of treatment outcome (e.g., base rate of risk predictors and treatment-unrelated 
regression toward the mean [Adamson et al., 2009]). However, optimal treatment 
outcome could also depend on influences both within and outside the therapeutic setting. 
An example of a structural change having occurred outside of the therapeutic 
setting included the use of continuing care interventions, such as the Alcohol Therapeutic 
Interactive Voice Response (ATIVR: Rose, Skelly, Badger, Ferraro, & Helzer, 2015). 
This approach used daily call-ins over four months which supported daily monitoring, 
provided feedback on progress, and engaged patients in their use of coping skills. 
Following a Cognitive Behavioral Therapy treatment, ATIVR was more effective in 
maintaining a low frequency of drinking over the four months of implementation (though 
no differences at the one-year follow-up) within those who were abstinent at the end of 
treatment (Rose et al., 2015). This is one example of an intervention made at the level of 
the community care model; however, many other changes could be made to intervene in 
patient education, access of services, and continuity of care for patients struggling to 
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change unhealthy patterns of alcohol use. Accordingly, continued learning about the 
influence of the community has yet to have provided clarification of the specific effects 
of community support on alcohol use, community-wide access to alcohol use, and 
specific supports/barriers to treatment within a community setting. 
As researchers have strived to better understand the impact of local communities 
on an individual’s patterns of alcohol use, this paper has attempted to explore factors 
constructed socially and culturally which have impacted recovery from unhealthy alcohol 
use. As the field has grown to examine larger factors that attempt to classify similar 
groups of individuals, researchers have increased their emphasis on data-analytic 
strategies. These data-driven methodologies have supported inferences of homogeneity 
within a classification, be it an individual-, community- or societal-level factor, and 
focus, ultimately, on causality to an identified outcome. As such, the remainder of this 
paper has been focused on implementation of multiple analytic methods (data-driven and 
theory-driven) in order to have continued the burgeoning literature that has focused 
evidenced-based treatments for the recovery from unhealthy alcohol use. 
 
 
The Current Study 
 
This study addressed two aims: 1) having used a data-driven approach to identify 
predictors (across the levels of the Bronfenbrenner model (Sudhinaraset et al., 2016) of 
AUD treatment outcome and 2) having confirmed a model of recovery from use driven 
by the above literature. The study sample consisted of individuals who attended Day One 
(a community-level intensive outpatient treatment center associated with the University 
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of Vermont Medical Center) from June 2011 – June 2012. As Day One has recently 
celebrated 30 years of providing treatment for co-occurring substance use and mental 
health disorders, it was timely to have examined the outcomes of Day One clients. A 
retrospective data set has been compiled (by the author) that includes multiple variables, 
many of which directly overlapped with factors identified above, others which have 
adequate proxy variables, and still others that represent additional constructs yet to 
formally assessed. 
Despite the advances which have occurred within the field of alcohol treatment, 
uncertainty has remained surrounding the definition of successful recovery from use, 
effective measures of alcohol use outcomes, reliable predictors of treatment outcome, and 
ability to generalize predictors of outcome across communities experiencing unhealthy 
alcohol use. In terms of generalizability, Grant and colleagues (2015) stated that samples 
of patients with alcohol dependence (AD) alone have been, “most typically represented in 
clinical trials of AD interventions, since they are a “clean” clinical trial population for 
whom the clearest inferences may most readily be drawn.” However, this group identified 
that individuals with AD alone represented only a portion of the community who have 
experienced unhealthy alcohol use, and may have increased likelihood of having remitted 
from use independently or with limited treatment (Grant et al., 2015; Mccutcheon et al., 
2014; Storbjork & Room, 2007). Thus, this study has examined the predictors of 
treatment outcome within a sample of patients which has not limited, via 
inclusion/exclusion criteria, the variability in levels of baseline alcohol use and comorbid 
mental health and/or substance use diagnoses. 
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Further, the current study has used both a data-driven approach to identifying 
predictors of treatment outcome, and subsequently a theory-driven approach to consider 
if a model of recovery could be substantiated within a community treatment program. 
Whelan and Garavan (2014) stated that within, “the general linear model, optimism [the 
degree of overfitting to the sample increased] as a function of the decreasing number of 
participants and the increasing number of predictor variables in the model.” Though 
optimism could be assessed by a number of means (as described by Whelan and Garavan 
2014), the utilization of nested cross-validation, as occurs within the Elastic Net 
Regularization approach, supported the identification of predictors that were statistically 
shown to relate to treatment outcomes, a marker of consistency and – perhaps – 
generalizability. In addition to the Elastic Net Regularization approach, we employed 
cross-validation which ensured optimization of the outcome variables and nested cross- 
validation to adequately define the model metrics (e.g., alpha and lambda). Using 
randomly generated 10-fold cross-validation, a model was developed within a sub-sample 
of participants (90% of the study group [e.g., the training set]) and tested for accuracy 
within a completely independent sub-sample (the remaining 10% [e.g., the testing set]). 
As this process was repeated, such that each 10% sample has been the “testing set,” the 
degree of over-fitting between each proven model was compared. Simultaneously, the 
penalties within the Elastic Net Approach were optimized within the training set via 
nested cross-validation. This paper used this novel approach to the analytic method, as it 
has provided greater clarity about the factors that reliably predicted outcomes for the 
treatment of unhealthy alcohol use. 
60  
The first objective of this study was the use of data-driven methodology to have 
examined the predictors of AUD treatment outcome within a community sample 
representative of outpatient treatment facilities within Vermont. Demographic (gender, 
employment, SES), substance-use (motivation to change and severity of use), 
sociological (general family social support, general friend social support, and changes in 
specific support for alcohol use), and psychological (rating of anxiety, rating of 
depression, and overall psychiatric severity) variables were used to identify significant 
predictors of reduced frequency of alcohol use following treatment. The Elastic Net 
Regularization approach prevented model overfitting by having estimated the accuracy of 
‘significant’ variables and strength of generalizability to other treatment samples. Having 
collected data within a longitudinal sample of treatment seeking clients in a community 
clinic has aided this goal of obtaining generalizable results. 
The second objective of this study was to determine the feasibility of applying 
theory-driven variables in having predicted changes in an individual’s frequency of 
unhealthy alcohol use following an abstinence-based treatment (e.g., the recovery model; 
Figure 2). This second hypothesis asserted the level of psychological symptoms would 
mediate the relationship between treatment outcome and baseline characteristics of the 
individual (including individual, microsystem, mesosystem, and macrosystem level 
variables). The literature has supported the development of a theoretically-driven 
psychosocial model, first proposed in this article. This model was used to examine the 
predictors of treatment outcome assessed at the initiation of treatment. Variables which 
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represented individual, microsystem, mesosystem, and macrosystem predictors, as well 
as psychological symptoms, were used to model alcohol treatment outcome. 
 
 
Figure 2: Theoretically-driven mediational model, demonstrating the impact of Individual, Microsystem, and 
Macrosystem level predictors being mediated through psychological distress to predict outcomes of treatment for 




Collection of Retrospective Data: 
 
Records were reviewed from patients seen at Day One from June 2011 - June 
2012. First, 250 variables were identified by the study team for inclusion in the research 
database. Prior to collecting this information, protocol exemption was finalized with the 
Committees on Human Subjects (CHRMS: 16-009) due to the plan to complete a routine 
de-identification step. Data coding was performed both to protect the identity of the 
patients included in the dataset and to minimize researcher bias during the analytic 
process. Each patient’s data was double-entered from paper charts, and data quality was 
assessed by identifying discrepancies between the two entries and resolving these with 
the paper (source) record. 
Inclusion Criteria: 
 
Inclusion criteria were minimal and included having completed an intake 
appointment and identifying alcohol use as a primary or secondary treatment target. 
Figure 3 shows the 323 total referrals (or self-referrals) during the study period; and the 
exclusions resulting in a final sample of 145 subjects who met inclusion criteria. For 
patients who began treatment more than once during the study period (N=7) only their 
first entry into the program was included. Other reasons for exclusion included: missing 
files (N=31; at referral [n=26] or post-intake [n=5]) and cancelled/missed intake 
appointments (N=43). Of the 145 patients seeking treatment for unhealthy alcohol use 
121 identified alcohol as a primary issue and 24 as a secondary issue. 
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Outpatient Treatment Setting: 
 
A full description of the Day One outpatient treatment setting is provided in 
Appendix 1 (Messina, Keithcart, Brown, Dees, and Reed ; unpublished). The Day One 
program is a long-standing division of the University of Vermont Medical Center’s 
(UVM-MC) Psychiatry department, which supports the treatment of co-occurring 
substance use and mental health disorders within an outpatient treatment setting. 
Treatment at Day One involves customization of treatment intensity (from one to three 
sessions per week), integration of comorbidity treatment, psychiatric intervention, and 
other treatment group specialties. These services are provided by four Licensed Alcohol 
64  
and Drug Counselors (LADCs) along with a psychiatrist. Together the team provides an 
ongoing assessment of active substance-related and mental health concerns and provides 




Data were collected at five points: phone screen, intake assessments, in-person 
interview, in-session measures, and treatment termination summary (Table 1). A 
description of the patient’s experience while engaging in these assessments can be 
garnered from Messina et al. (Appendix 1). 
The Phone Screen identified the current substance use and mental health concerns 
 
of patients and determined if Day One services were appropriate (e.g., appropriate level 
of care and ability to meet expectations for treatment). Appropriate patients were 
scheduled to visit the facility to complete an intake assessment packet. 
The Intake Assessments were a series of self-report and computerized measures, 
 
completed at Day One, that assesses a wide array of information across substance use, 
mental health, demographic, and social domains. Following the completion of these 
documents, patients were scheduled for an in-person session with one of the counselors. 
The goals of the In-person Interview were to: 1) obtain informed consent for Day 
 
One clinical services and 2) develop a collaborative treatment plan based on American 
Society of Addiction Medicine (ASAM) criteria. During the interview clinicians 
collected patient motivation for treatment, stage of change, urine drug screen, and a 
strengths-based description of treatment goals. Prior to the initiation of treatment, all 
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patients were described to the clinical team who collaboratively assigned an appropriate 
level of care to the patient according to clinical best-practices. 
In Session Measures were completed by both the clinicians and patients 
 
addressing attendance, patterns of use, and changes in level of service. At each session, 
clinicians recorded attendance (attended, cancelled, no-showed) and maintenance of 
abstinence. When patients were in attendance, they were regularly requested to report 
their success with maintaining abstinence since the last attended session. Further, patients 
were requested to complete urinalysis, influenced by patterns of non-abstinence, which 
provided confirmation of both alcohol and illicit substance use. 
A Treatment Termination Summary was completed via formal assessment 
 
between the patient and clinician. This included treatment duration and completion, 
current alcohol and substance use and overall functioning. The clinicians prepared a 
discharge summary including mental health diagnoses, treatment attendance, and details 
of discharge. In collaboration with the Day One treatment team, several metrics of 
treatment dosage were developed from content collected at termination, including months 
in treatment, relative measures of treatment engagement (i.e., dosage, compliance, non- 
compliance), and grouping into a measure of completer status (Attendance Grouping). 
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Table 1:Summary of the timeline of variable collection according to the point in which each measure was completed by 
client and/or mental health clinician. Red Variables were removed from the dataset due to missingness, or issues with 
data quality. 
 
Phone Screen Intake Assessment - Continued Interview During Treatment Termination - Continued 




· ASI Alcohol Severity 
 
· ASI Drug Severity 
 
· ASI Alcohol Composite 
 
· ASI Drug Composite 
· Education 
 
· Employment Status 
 
· Living Situation 
 
· Arrests at Onset 
· Clean Samples 
 
· Unclean Samples 
 
· Percent Clean Urine Drug Test 
 
· Abstained Sessions 
 
· Non-abstinence Sessions 
 
· SR Non-Abstinence 
 
· SR Abstinence 
 
· SR Missing 
· Reason for discharge 
 
· Pattern Frequency improvement 
 
· Overall Functioning 
 
· Route Alcohol 
 
· Outcome Frequency of Alcohol use 
 
· Outcome Social Connectedness Alcohol 
 
· Route Secondary Substance 
 
· Frequency Secondary Substance 
 
Initial Substance Use Status 
· # of days abstained from alcohol 
 
· # of days abstained from drug 
· Family History of substance use 
 
· Previous Treatment 
 
Initial Substance Use Status 
  · Age of Onset Alcohol 
 
· Route Alcohol 
 
· Initial Frequency of Alcohol use 
 
· Initial Social Connectedness Alcohol 
 
· Age of Onset Secondary Substance 
 
· Route Secondary Substance 
 
· Frequency Secondary Substance 
 
· Social Connectedness Secondary Substance 
 
· Relapse Risk 
 
· Relapse Risk Code 
 
· Readiness to Change 
  
Intake Assessment Psychological Status Treatment Dosage · Alcohol Change Score 
 
· Secondary Substance Change Score Demographics · Beck Anxiety Inventory 
 
· Beck Depression Inventory - II 
 
· Beck Scale for Suicide Ideation 
 
· ASI Psychiatric Severity 
 
· ASI Psychiatric Composite 
· Scheduled Sessions 
 
· Attended Sessions 
 
· Cancelled Sessions 
 





· Relationship Status 
 
· ASI Employment Severity 
 
· ASI Legal Severity 
 
· ASI Family/Social Severity 
 
· ASI Employment Composite 
 
· ASI Legal Composite 
 
· ASI FamilySocial Composite 
 
· Onset psychiatric services 
 
· Onset therapeutic services 
 
· Onset primary care physician 
 
· Financial Struggle 
 




· Transition Service 
 
· Number of Identified Goals 
· Months in Treatment 
 
· Attendance Grouping  
  · Percent Planned Sessions  
· Treatment Dosage 
 
· Treatment Compliance 
 
· Treatment NonCompliance 
 
· Discharge Date 
 
· Clincian Reported Sessions Attended 
 
· Aftercare plan 
 
· Total progress 
 
· Progress towards goals 
Health Status Termination 
· ASI Medical Severity 
 
· ASI Medical Composite 
 
· Care Access 
 
· Insurance Coverage 
 
· Transportation Difficulties 
 
· Other Access problems 
 
· AIDS Risk 
 Psychological Status 
Psychological Status · Final AxisI Diagnosis 
· Initial AxisI Diagnosis 
 
· Initial AxisII Diagnosis 
 
· Initial AxisIII Diagnosis 
 
· Initial AxisVI Diagnosis 
 
· Initial AxisV Diagnosis 
· Final AxisII Diagnosis 
 
· Final AxisIII Diagnosis 
 
· Final AxisVI Diagnosis 
 
· Final AxisV Diagnosis 
 





Using the Bronfenbrenner model, variables were reviewed according to when 
they were collected (Table 1), and which level (individual, microsystem, and 
mesosystem/macrosystem) they represented in the model (Table 2). 
Individual Level Variables: At the level of the individual, four classes of data were 
 
collected: substance use status (pre- and post-treatment), psychological status, health 
status, and demographic variables. 
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Baseline measures of alcohol and drug use severity were assessed via the 
Addiction Severity Index (ASI) during the initial intake assessment. The ASI is an 
interview-based instrument that assesses for potential problems among domains 
commonly impacted by substance use. These include: Medical, Employment/Support 
Status, Alcohol, Drug, Legal, Family/Social, and Psychiatric domains. Within the Day 
One program a multimedia version of the ASI was used, which allowed patients to 
complete the assessment at their own pace. Number of days abstained from alcohol and 
drug were collected during the initial phone intake and the remainder of the variables 
assessing baseline substance use status were collected during the screening interview. 
These included a description of all substances used (including substance class, age at 
onset, route of administration, and frequency of use), readiness to change use, previous 
treatment, and a clinician-assessed risk of relapse. Among the substance use variables 
were data collected during and after treatment completion. Those variables collected 
during treatment included clinician and self-reported abstinence and non-abstinence 
sessions. Post-treatment variables focused on the changes in secondary substances, 
including route, frequency, relative pre-post change in use. 
Among the psychological variables, the majority were assessed in the initial 
intake material. Self-reports were completed, including the Beck Anxiety Inventory 
(BAI: Beck & Steer, 1993), Beck Depression Inventory – Second Edition (BDI II: Beck 
& Brown, 1996), Beck Scale for Suicide Ideation (BSS: Beck & Steer, 1991), and a 
measure of psychiatric severity via the ASI (McLellan et al., 1992). The BAI is a 21-item 
self-report measure which allows patients to describe subjective, somatic, and/or panic- 
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related symptoms of anxiety on a scale from zero to three. Similarly, the BDI-II allows 
patients to self-report via 21-items on their experience of symptoms of depression with 
ratings made on a scale from zero to three. Finally, the BSS assesses for a patient’s 
suicidal intent via self-report on five screening items and sixteen follow-up items each 
with scales from zero to three. In addition, each patient completed a psychological 
assessment during the screening interview to determine diagnoses according to each of 
the Diagnostic and Statistical Manual of Mental Disorders – 4th edition (DSM-IV: APA, 
2013) axes (i.e. Axis I-V). All the variables assessing health were collected within the 
initial intake paperwork and interview. Patients self-reported AIDS risk, and overall 
medical severity via the ASI. Finally, patients reported a range of demographics in the 
initial intake paperwork, including their age, gender, race, ethnicity, educational 
attainment, and employment status. 
Microsystem Level Variables: At the level of the patients’ microsystem (Table 2), data 
 
was characterized primarily by demographic variables collected from the initial intake 
paperwork. This level targeted the influence of the patients’ immediate social influences; 
those individuals – may also be influences of objects or symbols – who participated in the 
life of the developing person on a fairly regular basis over an extended period of time 
(Hardcastle, Byrnes, Bartlett, Denton, & Walsh, 1981; pg. 22). The most direct 
assessment of these influences came from the ASI wherein patients report the level of 
distress/impairment within their family/social network. Additionally, patients provided a 
report of their relationship status (single, married, missing) and living situation. Finally, 
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each patient reported their family history of substance use prior to the initiation of 
treatment, within the initial intake paperwork. 
Mesosystem Level Variables: At the mesosystem level, variables addressed the 
 
relationships that exist between two or more settings/microsystems (Hardcastle et al., 
1981; pg. 25) and covered four classes of data: treatment dosage, demographics, 
substance use status (pre- and post-treatment), and health status variables. Patient-specific 
data was collected throughout treatment and after termination regarding patient’s 
engagement and process of treatment. These included measures of attendance (e.g., 
scheduled, attended, cancelled, and no-show sessions), relative dosage of treatment, 
compliance and non-compliance, duration of treatment, and progress towards their goals. 
Many of the factors assessing duration of patient engagement were adjusted based on 
each patients’ level of engagement, including percent planned sessions 
(attended/individual session goal), treatment dosage (attended/scheduled sessions), 
treatment compliance ([attended + cancelled sessions]/scheduled sessions), treatment 
non-compliance (no show/scheduled sessions), and progress towards treatment goals 
(number of identified goals/achieved goals at termination of treatment). 
Demographic variables addressed participant’s involvement with the legal system 
(number of arrests and ASI-assessed problems), employment concerns, and community 
treatment engagement (e.g., utilization of psychiatric, psychological and medical care). 
Each patient was also assessed, via interview, for their substance-specific social 
engagement for both alcohol and secondary substances prior to treatment initiation and 
for alcohol alone after treatment completion. Most patients provided a reason for 
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terminating treatment (completed, client left against medical advice, terminated by 
facility, transferred to another substance abuse treatment program, incarcerated, death, 
and other) and completed urine drug screens as determined to be necessary by the treating 
clinician. Finally, patients provided a dichotomous report, in the initial intake paperwork, 
of challenges they were experiencing surrounding access to care, insurance coverage, 
transportation difficulties, and other access problems. 
Macrosystem Level Variables: The processes between two or more settings (at least one 
 
without the individual) which indirectly contribute to their development, are identified as 
the macrosystem variables (Hardcastle et al., 1981; pg. 25). These include two discrete 
variables which assessed the degree of financial struggles each patient was experiencing, 
both via Yes/No and Likert-scale scores. This data was collected in the intake 
assessment. 
Table 2: Variables extracted from Day One client records 
 
Individual Level Factors Individual Level Factors Microsystem Level Factors Mesosystem Level Factors Macrosystem Level Factors 
Psychological Status Pre-Tx Substance Use Status Pre-Tx Substance Use Status Demographics Demographics 
BAI Days Abstain Alcohol Family History ASI Legal Severity Financial Struggle 
BDI II Days Abstain Drug Demographics ASI FamilySocial Severity Financial Struggle Degree 
BSS ASI Alcohol Severity Relationship Status ASI Legal Composite  ASI Psychiatric Severity ASI Drug Severity ASI Employment Severity ASI FamilySocial Composite  ASI Psychiatric Composite ASI Alcohol Composite ASI Employment Composite Psychiatrist  Initial AxisI Diagnosis ASI Drug Composite Living Situation Therapist Outcome Variables 
Initial AxisII Diagnosis Alcohol Age of Onset  PCP Intake  Initial AxisIII Diagnosis Alcohol Route Mesosystem Level Factors Arrests Onset Total progress 
Initial AxisVI Diagnosis Alcohol Frequency Treatment Dosage  Progress towards goals Initial AxisV Diagnosis Secondary Substance Age of Onset Months in Treatment Post-Tx Substance Use Status   Secondary Substance Route Scheduled Sessions Reason for discharge Post-Tx Substance Use Status  Secondary Substance Frequency Attended Sessions Alcohol Social Connectedness Pattern Frequency improvement Health Status Relapse Risk Attendance Grouping Clean Samples Overall Functioning 
ASI Medical Severity Relapse Risk Code Cancelled Sessions Unclean Samples Alcohol Route 
ASI Medical Composite Readiness to Change Noshow Sessions Percent Clean UDT Alcohol Frequency 
Aids Risk Previous Treatment Percent Planned Sessions  Alcohol Freq Change   Tx Dosage Health Status Alcohol_changescore  Post-Tx Substance Use Status Tx Compliance Care Access  Demographics Secondary Substance Route Tx NonCompliance Insurance Coverage  Age Secondary Substance Frequency Transition Service Transportation Difficulties Final AxisV Diagnosis 
Gender Secondary Substance changescore Discharge Date Other Access problems Change GAF 
Race Abstained Sessions Clincian Reported Sessions Attended  Change Education Ethnicity Nonabstinence Sessions Aftercare plan Pre-Tx Substance Use Status Change Employment 
Education SR NonAbstinence #Identified Goals Alcohol Social Connectedness Change Living Situation 
Employment Status SR Abstinence Treament Plan Duration 2 Substance Social Connectedness   SR Missing Treament Plan Sessions    
Treatment Outcome Variables 
 
From the data collected, there were a number of variables that could have been 
 
utilized as a potential outcome variable (Table 2). As described in the Definition of 
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Terms section (page 10), the metrics for assessing a recovery-oriented treatment outcome 
has been debated. For this study, the assessment of the frequency of alcohol use at the 
termination of treatment was selected as it was consistently recorded in a standard 
manner and is generally consistent with recommendations from the literature (Allen, 
2003; Anton & Randall, 2005; Sobell et al., 2003), e.g., focused on a measure of the 
amount and/or frequency in alcohol use. Of note, variables that measure other indicators 
of successful treatment including progress made towards treatment goals, global metrics 
of functioning, and measures of wellbeing are clinically important changes; however, a 





Objective 1 Analysis: Elastic Net Regularized Linear Regression 
 
In accordance with the primary objective of this study, a novel, data-driven 
methodology was employed to identify factors which predicted the frequency of alcohol 
use. The Elastic Net Regularization Approach was selected for the ability to enable 
shrinkage of the model, automatic selection of significant predictors, and independent 
selection of highly correlated variables (Zou & Hastie, 2005). The Elastic Net 
Regularization approach allows correlated variables to remain in the regression model, 
which is a desirable characteristic given the inter-correlations among the variables in 
Table 2. A ten-fold cross-validated regression framework was used for model building 
and to improve out-of-sample prediction. Within this study, the approach assessed the 
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predictors of the frequency of unhealthy alcohol use following engagement in substance 
abuse treatment via the Day One Intensive Outpatient Program. 
Prior to any data analysis, 25 subjects (approximately 17% of the sample) were 
selected as a “set-aside” sample. This group was not used in model building, but rather 
was an independent test set in which the final model was tested. The set-aside sample was 
stratified on subject age (Control= 37.96 [StDev=15.5255]; Testing= 38.3167 
[StDev=12.4509]), gender (Control= 40% female; Testing= 36.7% female), and 
education (Control= 13.48 [StDev=2.4685]; Testing= 13.8583 [StDev=2.4402]). 
The remainder of the data was used in the development of a model using the 
elastic net regularization approach and 10-fold cross-validation. This approach included 
two essential components: 1) k-fold cross-validation of the regression model within the 
“outer-fold” and 2) nested, k-fold tuning of the parameters (alpha and lambda) within the 
“inner-fold.” 
Within the outer-fold, 10-fold cross validation was used to develop a series of 
models from which the predictive strength of each variable was assessed. Within this 
approach a “training” set (k-1 of the folds; [n=108]) was used to develop a model of 
regression coefficients for each variable in relation to its prediction of the outcome 
variable (outcome frequency of Alcohol use). Finally, the model was tested for accuracy 
in the remaining data (the “testing” set, comprised of the last fold [n=12]). The predictive 
utility of this model was assessed by computing a receiver operator characteristic (ROC) 
curve and was summarized as the area under the curve (AUC). This process was repeated 
such that each fold was used as a testing set. The following 10 models were then utilized 
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to identify every variable which had shown significant predictive utility in a given model 
within the outer-fold analysis.  This process was repeated ten times with each fold 
serving as the testing data once. 
Within the inner-fold, 9-fold nested-cross-validation of the “training” set was 
used to tune the optimal values of the parameters (alpha and lambda). Similar to the 
outer-loop, the process used a k-fold strategy that examined a series of ten values for 
alpha (between zero and one) and lambda (logarithmic scale), which resulted in a 
parameter grid with 100 possible values. The models for each of these possible sets were 
developed on eight of the folds (n=96) and tested on the 9th fold (n=12). The AUC of 
these models was used to determine the optimal parameter set for the training set, which 
occurs independently for each of the ten outer-loops. These parameters added penalties to 
an ordinary least squares regression which optimized the variables included in the final 
model. It did so by managing the balance between the lasso penalty (influence on  
variable reduction) and the ridge penalty (degree of constraining correlated variables) as a 
function of the selected alpha, as well as the weight of the shrinkage/constraint these 
penalties had on the model as a function of lambda. In addition, the nested cross- 
validation approach removed cross-contamination that would have otherwise unduly 
increased the generalizability of the study (described further in Whelan & Garavan, 
2014). 
Following the development of these models, the variables that were identified as 
sufficiently predictive of outcome were remodeled on the sample of 120 individuals 
which enhanced the accuracy of the model coefficients, using parameters of alpha and 
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lambda that were specifically optimized for the full test sample. This optimized model, 
including the parameters, was tested on the set-aside group which assessed the 
generalizability (via AUC) of the final model to a separate group of data. 
 
 
Objective 1: Data Cleaning 
 
Prior to the completion of the elastic net regularized regression the data was 
assessed for missingness, and variables with more than 20% missingness were removed 
(see Data Cleaning below). Given that this data was from patient records, a certain 
amount of missing data was expected, thus a cutoff of 20% missingness within a subject 
was applied, which did not result in removal of any subjects. Variables were tested for 
normality and skewness and/or kurtosis was recorded such that the impact on outcomes 
could be considered. Because of the strength of the elastic net regression and preference 
for interpretability, only limited data transformations were completed (see the results 
section). Outliers were defined as greater than 2.5 standard deviations above the variable 
mean and again recorded for interpretation of effect on the study results. 
 
 
Objective 2: Application of a Theoretically Derived Model 
 
The second objective of this study was to test a theory-driven model of predictors 
of treatment outcome. Variables were selected as they applied to the reviewed literature 
for predictors of the initiation and maintenance of unhealthy alcohol use (Table 3). We 
expected psychological symptoms to mediate the impact of individual, microsystem, 
mesosystem, and macrosystem level predictors on treatment outcome (as depicted in 
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Figure 2). Variables were limited to those collected before treatment began (i.e. baseline 
characteristics) as mental health variables were only collected at one time point. First, 
variables were assessed for a significant correlation to the outcome variable to determine 
the appropriateness of inclusion into the regression model. To reduce redundancy, where 
two variables represented the same construct both theoretically and statistically 
(correlation >0.5), one of the variables was removed. Path analysis was performed to test 
the theoretical model (Figure 2). All analyses were conducted using the SPSS System’s 
PROCESS macro, version 3.2 (Hayes, 2017). These analyses used maximum likelihood 
estimation and were performed on the variance‐covariance matrix. Due to the relatively 
small sample size, the results of the path analysis should be considered exploratory. 
Table 3: Theory-driven variables selected from Day One retrospective data collection and described in relation to 
predictors of initiation and maintenance of unhealthy alcohol use within the literature 
 
Individual Factors Description of influence from the  literature 
Contribution of initial sensitivity of alcohol use and ongoing influence of 
motivational readiness, or the balance between self-efficacy and 
temptation  (Positive Reinforcement) 
Development of tolerance and withdrawal avoidance in the early stages  
of addiction and ongoing increased risk for maintenance and relapse for 
individuals with high severity of alcohol  use 
Development of tolerance and withdrawal avoidance in the early stages  
of addiction and ongoing increased risk for maintenance and relapse for 
individuals with high severity of alcohol  use 
A conglomeration of factors contributing to the occurrence of relapse 
likely to include stress reactivity, emotional impulsivity, motivations for 










Initial influences of motivations for social conformity and ongoing 
difficulties managing distress within their social support   setting 
 
Initial influences of social disadvantage and bio-psycho-social 
consequences as well as ongoing structural inequalities in the 
availability, adequacy and comprehensiveness of available   treatments 
 
Predisposition for psychological distress and ongoing disruption 
individually and interpersonally in the individuals   functioning 
ASI Family/Social Severity 
 
PCP Intake 
Beck Depression Inventory - II 
 
Readiness to Change 
 









As described above, variables were assessed for missingness and removed 
using an 80% cut-off rule (no more than 20% missingness). This resulted in several 
variables being removed from the dataset (Table 1). These included all of the variables 
assessing a tertiary substance use concern, as well as details of drug use behaviors, 
baseline relationship status, creation of an aftercare plan, and clinican rated relapse risk. 
For patients reporting a secondary substance concern (n=58) substance use frequency 
pre/post was retained in the data set as 80% of the sub-set had complete data. Data on 
secondary substance use was re-coded to include all subjects (i.e. a new category was 
generated (coded as 0), indicating no history of reported unhealthy use). For the variable 
of days since last substance use, non-users were given a maximum value of the age of the 
patient in days. All missingness was corrected utilizing basic imputation strategies which 
were based on the format of the variable, as well as metrics of normality. For categorical 
variables and those with distribution issues (skewness or kurtosis), the median value of 
the variable was used. For continuous variables with normal distribution the mean of the 
variable was used. Finally, several variables were excluded as not relevant to the analysis 
(i.e. discharge date, route of alcohol use), or because they were not able to be 
meaningfully coded (mental health diagnoses, treatment plan sessions, reason for 
discharge, termination summary, change in demographics during treatment). 
Missingness was also assessed at the level of the participant, and no records were 
removed (i.e. no subject had >20% missingness). Sixteen variables were found to include 
outliers, defined as greater than 2.5 standard deviations above the variable mean. These 
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were not removed as the analytic method is robust to outliers, and none of the variables 
could be determined to be invalid. Three variables had 4 or more outliers AIDS Risk (5 
outliers); Clean Urine Samples (4 outliers); Self-Reported Non-Abstinence (4 outliers). 
Though no corrections were made for these variables, they are noted to aid in considering 






Demographics of the 145 subjects included are presented in Table 4, including 
characteristics of co-morbid substance use and other mental health concerns. Referral 
sources included the legal system, substance use treatment programs (residential, 
outpatient, and dual diagnosis), mental health services (outpatient, IOP, inpatient), 
primary care providers, student health, employee assistance programs, and self-referrals. 
Table 4: Demographics of the patient sample 
 
 
The gender distribution (37% Female) was consistent with national prevalence 
rates (NSDUH, 2016). Age appeared evenly distributed with an average of 38.26 years 
(SD=12.97). The racial diversity of the patient sample was consistent with that of the 
Gender  








18-29 45 (31%) 
30-45 51 (35%) 





Marital Status  
Married 34 (23.5%) 
Single 77 (53%) 
Not Reported 34 (23.5%) 
  
 
Racial Identity  









Bi-racial 1 (1%) 
Ethnicity  





None 89 (61%) 
1-3/month 37 (26%) 
1-2/week 11 (8%) 
3-6/week 4 (3%) 














SU & MH 
Disorders 
26 (19%) 





















demographic area, including when the sample was compared to government estimates for 
Chittenden county (Χ2=2.034, p=0.565: US Census Bureau, 2016). However, the sample 
notably did not include any patients of Latino/a ethnicity. Most of the sample was single 
(53.1%), though marital status had the largest degree of unreported data (23.45%). On 
average, it took a little over two weeks (18 days) from referral to completion of the intake 
assessment, and 11 days from intake to beginning treatment. Once engaged in treatment, 
patients completed an average of 12 sessions, with 2.4 cancelled and 1.6 no-show 
sessions. Treatment resulted in 61% of participants reporting abstinence at the end of 
treatment (Table 4). 
Objective 1: 
 
Prior to the initiation of the Elastic Net Regularization approach, four multi-level, 
categorical variables were transformed to continuous variables to capture the full 
variance of patient responses. For example, the initial frequency of alcohol use was 
originally an ordinal variable (levels 1 through 5) and was transformed to be a 
quantitative measure of occurrences of alcohol use within the past month (0, 2, 6, 18, 28). 
Variables that were transformed included initial frequency of alcohol use, social 
connectedness (i.e. having a recovery community) both at the start and end of treatment, 
and onset secondary substance use frequency. Alcohol frequency at the end of treatment 
(the outcome variable) was kept categorical due to wide variation between participants 
(Mean = 2.30, St.Dev. = 5.41) and the non-normality of the resulting distribution 
(skewness = 3.70 and kurtosis = 13.80). 
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To contend with issues of generalizability and model overfitting, (as noted by 
(Whelan & Garavan, 2014), the full analysis (detailed below) was run 9 times using 
different random seeds for randomization of subjects into the k-fold structures. The 
results were assessed for the overall consistency of the predictive models via two types of 
data: 1) model performance (e.g., the variability in the degrees of freedom and % 
variance explained by each model) and 2) variable consistency (e.g., frequency of 
occurrence in the final model). 
The set of nine models demonstrated fairly wide variation in the number of 
predictors (degrees of freedom) and a great deal of consistency in explanatory power. As 
seen in Table 5, the number of variables for each model ranged from 14 to 31. This 
suggested that the charteristics of the group influenced variable selection at the sub-run 
level. Interestingly, these models were relatively consistent in the amount of variance 
explained (average adjusted R2 = 0.316 ± 0.025; range 0.264 to 0.345). The stability of 
model performance suggests a strong underlying model with several variables that were 
impacted by the particular patients randomized into a given fold. 
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Table 5: Replication of Final Restricted Model for the prediction of outcome 
frequency of Alcohol use following abstinence-based treatment 
 
Run DOF R^2 
1 19 0.32635 
2 19 0.32635 
3 31 0.34488 
4 26 0.26416 
5 23 0.31251 
6 19 0.33045 
7 18 0.28475 
8 23 0.32678 
9 14 0.32509 
AVG (StDev) 21.33333 (5.02549) 0.315702 (0.0253) 
 
 
The second metric of the generalizability of the elastic net models was variability 
across runs. In the examination of the 9 final restricted models, a total of 40 variables 
were present in at least one of the models (Table 6). Variables were categorized based on 
the consistency of inclusion within a model across the 9 models, which resulted in a 
frequency of a variables occurrence ranging from 0%-100%. This data was used to 
categorize variables into high (>75% of models), medium (between 25% and 75% of 
models), and low (<25% of models) frequency groups. Across the nine runs there were 
15 high frequency, 7 medium frequency, and 8 low frequency variables. As depicted in 
Table 6, variables indicated as predictive within fold-based models were found to be 
significant in an average of approximately four final, restricted models. In addition, 10 
variables were only predictive at the level of the folds within a run (e.g., produced no 
significant coefficient in a final, restricted model). The most consistent variables were 
individual patient characteristics and treatment process variables; however, social 
systems and societal level variables were also present. 
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Table 6: Variables reported across the nine runs to be predictive of the frequency of alcohol use following abstinence- 
based treatment 
 
Final Variables Variable occurrence within 
final model 
Models 
INDIVIDUAL # of models % of models  
ASI Drug Severity 0 0% None 
ASI Medical Composite 0 0% None 
Employment Status 0 0% None 
Initial Axis I Diagnosis 0 0% None 
Self-Reported Abstinence 0 0% None 
Age 1 11% 3 
Number of days abstained from drug use 1 11% 3 
Race 1 11% 3 
Number of days abstained from alcohol 2 22% 3, 8 
ASI Inconsistency 4 44% 1-4 
ASI Drug Composite 4 44% 3-5, 8 
AIDS Risk 4 44% 3-6 
Onset age of Alcohol use 5 56% 3-5, 7, 8 
ASI Skipped 5 56% 3-6, 8 
Secondary Substance Change score 9 100% 1-9 
Non-abstinence Sessions 9 100% 1-9 
Outcome Secondary Substance Frequency 9 100% 1-9 
Beck Depression Inventory - II 9 100% 1-9 
Readiness to Change 9 100% 1-9 
Initial Alcohol Frequency 9 100% 1-9 
ASI Alcohol Composite 9 100% 1-9 
MICROSYSTEM    
Family History of substance use 2 22% 3, 8 
Living Situation 2 22% 3, 4 
MESOSYSTEM    
Onset therapeutic services 0 0% None 
Arrests at Onset 0 0% None 
Transportation Difficulties 0 0% None 
Scheduled Sessions 0 0% None 
Percent Planned Sessions 0 0% None 
Treatment Compliance 2 22% 1, 2 
Percent Clean Urine Drug Test 2 22% 3, 4 
Outcome Alcohol Social Connectedness 6 67% 1-5, 8 
Treatment Non-Compliance 7 78% 3-9 
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Table 6 (Continued) 
MESOSYSTEM (continued)    
Onset psychiatric services 8 89% 1-8 
Primary Care Physician at Onset 8 89% 1-8 
ASI Legal Severity 8 89% 1-8 
Attended Sessions 9 100% 1-9 
Months in Treatment 9 100% 1-9 
Treatment Dosage 9 100% 1-9 
Attendance Grouping 9 100% 1-9 
MACROSYSTEM    
Degree of financial struggle 3 33% 3-5 
 
 
The content and form of the nine generated models has been illustrated through 
the detailing of a representative, example model. In the process of generating this final 
representative model, ten folds were completed to establish a set of variables predictive 
of outcome frequency of alcohol use. We examined the consistency of variable inclusion 
across folds in order to recognize the potential contibution of participant randomization 
within the process of model generation. Examining the results of the ten folds within this 
model, there was notable variation in the number of variables (with degrees of freedom 
ranging from 7 to 24 [mode=10]) and in the regression coefficients within each of the ten 
fold-based models (ranging from -0.45608 to 0.46353 [mean=0.190693]). This 
representative model had 23 total variables, including 100% of the high frequency 
variables (>75% of models), 57% of the medium frequency variables (25% - 74%), and 
11% of the low frequency variables (<25%). 
Seventy-five percent of the fold-based models identified ASI alcohol composite, 
readiness to change, initial alcohol frequency, attendance grouping, Beck Depression 
Inventory - II, dosage of treatment, change in the level of secondary substance use at the 
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end of treatment, and clinician reported non-abstinence sessions which demonstrated 
striking consistency of the strongest predictors. Variables that appeared less consistently 
in the models (ranging from 40 to 10% of the fold-based models) included: treatment 
duration (in months), clinician-reported session attendance, relative amount of no-show 
sessions, ASI legal severity, ASI metric of the possibility of change in drug use problems, 
onset psychiatric services, days of pre-treatment alcohol abstinence, inconsistency in ASI 
reports, pre-treatment primary care physician, onset age of Alcohol use, family history of 
substance use, outcome engagement with social groups supportive of alcohol recovery, 
percent of the prescribed treatment completed, and the pre-post change in substance use. 
The strength of the regression coefficients for the predictive variables (Table 7) ranged 
from +/- 0.00019 to 0.92 (mode=-0.17). 
Overall, the model shows that treatment non-compliance is the strongest predictor 
of outcome (greater non-compliance related to a worse outcome), and that variables 
included in the final model were represented across most of the levels of the 
Bronfenbrenner model. 
85  
Table 7: Representative Model of the predictors of alcohol frequency 
following an outpatient abstinence-based treatment program 
 
 






Individual   
Non-Abstinence Sessions 0.066 80% 
Outcome Secondary Substance Frequency 0.02 90% 
Secondary Substance Change score 0.011 10% 
ASI Alcohol Composite 0.63 100% 
ASI Drug Composite 0.25 20% 
Initial Alcohol Frequency 0.022 100% 
Beck Depression Inventory – II 0.00091 90% 
Number of days abstained from alcohol -0.00019 10% 
Onset age of Alcohol use -0.0043 10% 
ASI Skipped -0.018 10% 
Readiness to Change -0.095 100% 
Microsystem   
Family History of substance use -0.026 10% 
Mesosystem   
Onset psychiatric services 0.079 20% 
Outcome Alcohol Social Connectedness -0.0019 10% 
Attended Sessions -0.005 30% 
Months in Treatment -0.0085 40% 
ASI Legal Severity -0.025 20% 
Attendance Grouping -0.17 90% 
Primary Care Physician at Onset -0.17 10% 
Treatment Dosage -0.36 90% 
Treatment Non-Compliance -0.92 30% 
 
 
At the individual level, readiness to change (internalized motivations for 
abstinence) was consistently included (100% of the ten folds) as a negative predictor (i.e., 
the higher the readiness to change the lower the alcohol use at the end of treatment). In 
addition, initial frequency of alcohol use and the composite measure of alcohol use from 
the ASI were constant, positive predictors (i.e., the amount and challenges with alcohol 
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use directly related to greater frequency of alcohol use at outcome). Other variables in the 
model measured the history and degree of alcohol and drug use (i.e. duration of 
abstinence from alcohol and age of drinking onset), baseline depression, and alcohol use 
during treament among others (Table 7). Both baseline variables and individual factors 
measured throughout treatment were included in the model. In summary, several 
individual level variables were found to be important predictors of outcome. 
 
At the level of the microsystem, only one variable (family history of substance 
use) significantly contributed to the prediction of outcome. Interestingly, the direction of 
the relationship was that having a positive family history of substance use was predictive 
of a better treatment outcome (a greater decrease in alcohol use frequency). Further 
examination of this dichotomous variable using a Chi-Square analysis with Yates 
correction, indicated that the frequency of alcohol use at the outcome of treatment was 
not significantly impacted by a patients family use histories (Χ2[4,N=145] = 5.80, p = 
0.22). As presented within Table 8, there appears to be somewhat of an influence for 
patients having reported high frequency of use within the past month, though the sample 
sizes are much to small to provide conclusive evidence. 
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Table 8: Chi-square table demonstrating the relationship between family history of substance use and post-treatment 
frequencies of alcohol use. 
 
EXPECTED NULL HYPOTHESIS Family History of substance use 





























At the level of the mesosytem, several variables remained in the final, restricted 
model predicting a reduction in use. These included variables related to engagement in 
treatment (greater engagement related to better outcome), variables related to being part 
of a recovery community, and baseline characteristics such as having a primary care 
physician or legal problems. Interestingly, while having a primary care physician was 
related to better outcomes, having a psychiatrist at onset predicted a worse outcome. 
Given the surprising finding regarding having an outpatient psychiatrist, this was further 
explored. The results of a Chi-Square analysis with Yates correction indicated a non- 
significant relationship between outcome frequency of Alcohol use and engagement in 
outpatient psychiatric services (Χ2[4,N=145] = 3.78, p =0.44). As can be seen in Table 9, 
there a very slight indications of underperformance of treatment for those with 
psychiatric outpatient services (e.g., less in the none and more in the mild and moderate 
frequency groups). In summary, it appears that the context of a patients environment – 
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particularly medical and legal, duration of treatment attendance, and respective 
engagement in treatment (maybe even particularly when noncompliant) have a marked 
impact on changes in the frequency of alcohol use. 
Table 9: Chi-square table demonstrating the relationship between Onset psychiatric services and post-treatment 
frequencies of alcohol use. 
 
EXPECTED NULL HYPOTHESIS Onset psychiatric services 






























The second aim of this study was to test a predictive model of recovery from 
alcohol use (Figure 2) using theoretical constructs taken from the literature. We 
hypothesized that psychological symptoms would mediate the relationship between 
treatment outcome and baseline characteristics of the individual (including individual, 
microsystem, mesosystem, and macrosystem level variables). All of the 41 predictor 
variables (grounded in the recovery literature) were assessed prior to the patients 
engagement in treatment services, as follows: 
Individual factors (14 variables assessed): Readiness to Change, ASI 
Alcohol Severity/Composite, Number of days abstained from alcohol, 
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Alcohol Frequency, Relapse Risk, Onset age of Alcohol use, secondary 
substance frequency, Onset age of secondary substance use, ASI Drug 
Severity/Composite, Previous Treatment, Education, Age, Gender, and 
Race. 
 
Microsystem factors (8 variables assessed): Family History of substance 
use, Initial Alcohol Social Connectedness, Initial Secondary Substance 
Social Connectedness, Relationship Status, ASI Legal 
Severity/Composite, Arrests at Onset, ASI Family/Social 
Severity/Composite. 
 
Mesosystem factors (11 variables evaluated): Insurance Coverage, 
Transportation Difficulties, Other Access Problems, Degree of financial 
struggle, Employment Status, ASI Employment Severity/Composite, 
Onset psychiatric services, Onset therapeutic services, and Onset primary 
care clinician. 
 
Macrosystem factors (4 variables assessed): Care Access, Identified Goals, 
Treatment Plan duration and Treatment Plan sessions. 
 
Psychological distress (4 variables assessed): Beck Anxiety Inventory, 
Beck Depression Inventory – Second Edition, Beck Scale for Suicide 
Ideation, and ASI Psychiatric Severity/Composite. 
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We first examined correlations between the identified predictor variables 
and the outcome (change in frequency of alcohol use). Nine variables were 
significantly correlated with the outcome variable at the end of abstinence-based 
treatment (Table 10). These variables were examined for potential collinearity by 
examining the correlation coefficients between the independent variables, 
employing a stringent threshold of 0.75 due to concerns of the sample size 
(previous research employed a 0.95 threshold [Zainodin & Yap, 2013]). The 
theoretical implications of the severity of alcohol use was the driving force for 
removal of two, highly-correlated, variables (Table 10), and the final incusion of 
7 variables in the model. 
Table 10: Treatment predictors correlation to the outcome frequency of alcohol use, including removed variables. 
 
Individual Factors  
Readiness to Change -0.336** (p=0.000036) 
ASI Alcohol Severity 0.219** (p=0.008214) 
ASI Alcohol Composite 0.340** (p=0.000029) 
Initial Frequency of Alcohol Use 0.438** (p=3.4994E-8) 
Relapse Risk 0.174* (p=0.037) 
Microsystem Factors 
ASI Family/Social Severity 0.198* (p=0.016931) 
ASI Family/Social Composite 0.205* (p=0.013514) 
Mesosystem Factors 




Beck Depression Inventory - II 0.204* (p=0.013948) 
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The restricted variables were systematically entered into mediation analyses using 
the SPSS macro PROCESS (Hayes, 2017) with frequency of alcohol use at the end of 
treatment as the outcome and Beck Depression Inventory - II as the mediator (Table 11). 
As depicted in Figure 4, the analysis tested the direct relationships between baseline 
characteristics and psychological distress (a-paths), psychological distress and outcome 
(path b), baseline characteristics and outcome (c-paths), as well as mediation through 
psychological distress of baseline characteristics on outcome frequency of alcohol use 
(c’-paths). On the a-path, ASI Family/Social Severity significantly predicted higher BDI- 
II scores (B=3.55, SE=0.5023, t=7.0723, p<0.001). Notably, the b-path between 
psychological distress and treatment outcome was non-significant (B=0.0556, 
SE=0.8863, t=1.7013, p= 0.0911) when controlling for the other predictors. 
The results of the c-path indicated a number of variables which significantly 
predicted the outcome variable. Among the individual variables, readiness to change (B= 
-0.5908, SE=0.1532, t=-3.8572, p= 0.0002) and initial frequency of alcohol use 
(B=0.2706, SE=0.05175, t=4.7054, p<0.001) were found to be predictive of treatment 
outcome when controlling for the other predictors. While the microsystem variable 
approached significance, ASI Family/Social Severity (B=0.2572, SE=0.1941, t=1.8413, 
p=0.0677), the mesosystem variable was found to significantly predict the outcome 
frequency of alcohol use, onset primary care physician (B=-2.1956, SE=0.8842, t=- 
2.4833, p=0.0142). 
The results of the c’-path also demonstrated several variables which maintained 
significant predictive power for the outcome variable when mediated by psychological 
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distress. As can be observed within Table 11, these included readiness to change (B= 
 
-0.5732, SE=0.1525, t=-3.7593, p=0.0003), initial frequency of alcohol use (B=0.2721, 
SE=0.0571, t=4.7637, p<0.001), and primary care physician at onset (B=-2.4, 
SE=0.8863, t=-2.7078, p=0.0076). The results of these analyses determined that within 
this subject group there were no significantly mediated pathways through psychological 
distress, as noted by all indirect effects overlapping zero (Table 11). 
Table 11: Mediation Analyses (N=145) 
 
a path (X→M, controlling for other baseline predictors) c path (X→Y, controlling for other baseline predictors) 
X M      X Y  
  B SE T p    B SE t p 
RtC BDI-II -0.32 0.4 -0.8 0.4262  RtC OFoAU -0.59 0.15 -3.86 <0.001*** 
ASIAS BDI-II -0.21 0.5 -0.41 0.6797  ASIAS OFoAU 0.16 0.19 0.84 0.4016 
FoAU BDI-II -0.03 0.15 -0.18 0.8539  FoAU OFoAU 0.27 0.06 4.71 <0.001*** 
RR BDI-II 1.69 1.49 1.13 0.261  RR OFoAU -0.25 0.58 -0.44 0.6608 
             
ASIFSS BDI-II 3.55 0.5 7.07 <0.001***  ASIFSS OFoAU 0.26 0.19 1.84 0.0677* 
             
PCP BDI-II 3.68 2.29 1.61 0.1104  PCP OFoAU -2.2 0.88 -2.48 0.0142* 
 
c' path (X→M→Y, controlling for other baseline predictors) 
X M Y Indirect effects 
 B SE T p  Effect SE * LLCI * ULCI * 
RtC BDI-II OFoAU -0.57 0.15 -3.76 <0.001***  -0.02 0.03 -0.08 0.02 
ASIAS BDI-II OFoAU 0.17 0.19 0.91 0.3663  -0.01 0.03 -0.09 0.05 
FoAU BDI-II OFoAU 0.27 0.06 4.76 <0.001***  -0.002 0.01 -0.03 0.02 
RR BDI-II OFoAU -0.35 0.58 -0.6 0.5472  0.09 0.11 -0.07 0.38 
          
ASIFSS    BDI-II OFoAU 0.16 0.23 0.71 0.4784  0.2 0.12 -0.03 0.44 
          
PCP BDI-II OFoAU -2.4 0.89 -2.71 0.0076**  0.2 0.17 -0.07 0.58 
 
 
Note. X=independent variable (Initial Predictors: Readiness to Change [RtC], ASI Alcohol Severity [ASIAS], initial 
Frequency of Alcohol Use [FoAU], Relapse Risk [RR], ASI Family/Social Severity [ASIFSS], and Onset primary care 
physician [PCP]). M=mediator (Psychological Distress: Beck Depression Inventory - II). Y=dependent variable 
(Outcome of Treatment: outcome frequency of Alcohol use). SE=standard error; CI=confidence interval. All models are 
ordinary least squares regressions controlling for other baseline predictors. 




Figure 4: Completed model of the prediction of the frequency of alcohol use at outcome of treatment via theory-driven 




The Day One Intensive Outpatient Program was effective with 61% of the sample 
reporting no alcohol use (within the past month) at the end of treatment. This success rate 
is consistent with treatment outcome literature described by (Moos & Moos, 2006). The 
goal of this study was to advance knowledge of the predictors of treatment success using 
both data-driven and theory-driven analytic methods. The results are summarized below 
separately and together to guide future research efforts. 
Objective I: 
 
The data-driven, Elastic Net Regularized regression was used to identify 
predictors of the primary outcome, frequency of alcohol use at the end of treatment. Five 
categories of variables found to consistently predict the frequency of alcohol use (e.g., the 
high and medium frequency variables) are presented below. These variables were 
identified in the out-of-sample test set, and thus are representative of both this sample and 
the wider population of patients in abstinence-based recovery. As such, these concepts 
may have importance in the process of assessment and throughout treatment. 
The first set of constructs are measurements of alcohol use at the beginning of 
treatment (initial frequency of alcohol use) and associated problems in functioning (ASI 
Alcohol Composite). These two variables were represented in 100% of models and have 
a positive relationship with the outcome variable frequency of alcohol use (i.e. more 
alcohol use at intake is related to more alcohol use at the end of treatment; a worse 
outcome) with moderate and weak correlational strength, respectively. These results 
provide an important reminder that assessing the starting point for a patient’s recovery is 
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important for understanding the outcome of treatment. This also suggests that a harm- 
reduction model – that is strategies for reducing alcohol use – may be a useful precursor 
to successful abstinence-based treatment. 
The second set of constructs which consistently predict outcome are co-occurring 
mental health conditions, particularly depressive symptoms, and onset therapeutic 
services. Both variables were found in the majority of final models. Those patients with 
fewer depressive symptoms at intake had lower alcohol use at the end of treatment. 
Paradoxically, those who reported having an outpatient psychiatrist had higher alcohol 
use at the end of treatment. It may be that having an outpatient psychiatrist at intake is a 
proxy for the severity of the mental illness, or for treatment resistance (as their addiction 
was not treated in the course of outpatient psychiatric treatment). These results provide 
information supporting the known impact of mental illness on addiction (Burns et al., 
2005; Gilder et al., 2016; Glass et al., 2014; Grant, Goldstein, Saha, Chou, Jung, Zhang, 
Pickering, Ruan, Smith, Huang, Hasin, et al., 2015; Helzer & Pryzbeck, 1988; Johnston 
et al., 1991; Kaufmann et al., 2014; Kushner et al., 2005; Malcolm et al., 2006; Mann et 
al., 2004; McCallum et al., 2016; Mellentin et al., 2015; Newton-Howes et al., 2017; 
Sánchez-Peña et al., 2012; Schellekens et al., 2015). In addition, these results support 
integrated treatment addressing mental health and addiction in a coordinated manner. 
The third construct related to treatment outcome is readiness to change, as greater 
initial motivation to change is related to lower alcohol use at the end of treatment. While 
this variable was identified in 100% of the models, it has a very weak correlation with 
outcome. This may suggest that motivation is necessary though not sufficient for 
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benefitting from treatment. However, a large literature demonstrates the effectiveness of 
motivational interviewing (Elliott et al., 2014; Miller & Rollnick, 2002; Morgenstern et 
al., 2012), and this finding further supports treatments that integrate efforts to support 
patients in developing and sustaining motivation for change, including enhancing self- 
efficacy and directly addressing risks for relapse. 
The fourth construct consistently identified is substance use during treatment, 
both lapses of alcohol use and the frequency of using other substances during treatment. 
Fewer lapses were associated (weakly) with a positive treatment outcome in every model. 
Interestingly the weak relationship of lapses to treatment outcome suggests that even in 
abstinence-based treatment lapses do not preclude successful treatment. This is consistent 
with treatment literature demonstrating alcoholism as a relapsing and remitting disease 
(Allen et al., 1997; Heyman, 2013; Heyman & Mims, 2010; Marlatt, 1996; Moos & 
Moos, 2006; Pickard, 2016; White, Scott, Dennis, & Boyle, 2005; Zywiak et al., 1996). 
As such, the treatment process of re-committing to goals and strengthening motivation to 
change after a lapse may be beneficial. The use of other substances at the end of 
treatment was associated with greater alcohol use (a worse outcome) in 100% of the final 
models. This suggests that considering all substance use during treatment is paramount to 
treatment of problematic alcohol use. Stated a different way, the attitude that using 
marijuana (53% of the reported secondary substance), does not affect drinking and/or is 
somehow preferable to using alcohol, is not supported by this study. Though not directly 
assessed in this study, there may be different treatment trajectories related to the profile 
of co-occurring disorders (substance alone [23%] or with mental health concerns [19%]). 
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Further studies addressing how the level and/or duration of treatment within the intensive 
outpatient program, or how collaboration with additional treatments (e.g., medication 
assisted treatment, mental health counseling, Narcotics Anonymous, etc.) works for 
patients with different diagnostic profiles will be important. 
The fifth and final essential construct is the patient’s engagement in treatment. 
 
While this is an intuitive finding, it is one with nuanced clinical implications. For 
example, this study found that the absolute amount of treatment (months in treatment 
and/or number of sessions) predicted better outcomes, as did consistent treatment 
attendance (attended/scheduled sessions and no-show/scheduled). However, the number 
of sessions that were cancelled or that the client “no-showed” did not predict treatment 
outcome. Clinical interpretation of patterns of non-attendance typically include lower 
motivation or commitment in patients who “no show” to sessions, and the reverse for 
“appropriately cancelled sessions”, and this would be assumed to be related to treatment 
outcome. This has direct clinical implications for encouraging a patient’s efforts to attend 
sessions even if they are inconsistent. Further this finding supports treatment program 
efforts to reduce barriers for engagement in treatment and to work on enhancing 
motivation for recovery. Questions in our field remain regarding the variables which best 
predict decision making within the course of each patients’ recovery treatment, including 
when treatment may be unhelpful, when to transition patients to a different type/level of 
treatment, and when is it appropriate to administratively discharge patients. For example, 
White and colleagues (2005) review the rationale for “kicking out patients” and suggest 
alternatives for administrators and clinicians. This finding falls in line with the suggestion 
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of enhancing efforts to sustain patient engagement and limiting the interpretation of 
missed sessions. 
While the 5 constructs above are the most consistent factors found across the 
predictive models, each model demonstrated variability in significant predictors which 
suggests an impact at the level of the individuals included in model development. For 
example, the presence of a family history of substance use (a microsystem level variable) 
was a weak predictor of alcohol use at the end of treatment, such that having a family 
history of substance use predicted better outcomes. While much literature associates 
family history of substance use with poorer outcome (Capaldi et al., 2013), it has been 
suggested that family history may serve as a proxy risk variable which may be better 
measured by other variables, including psychosocial stressors, craving or baseline alcohol 
consumption (Adamson et al., 2009; Johnson et al., 2000). Thus, utilizing information 
about an individual’s family history of substance use within treatment may end up being 
helpful in predicting modifiable patterns of use and motivations for recovery which are 
well suited to change within IOP treatment. 
At a societal level, a person’s degree of financial struggle was a weak, positive 
predictor of outcome in several models (i.e. less financial struggle was associated with 
less alcohol use at the end of treatment). Interestingly, several studies have demonstrated 
differential trajectories of treatment engagement and success as a result of the interaction 
of socioeconomic status and racial group, with worse outcomes observed for low SES, 
Black- and Hispanic-identified patients (Lewis, Hoffman, Garcia, & Nixon, 2018; 
Saloner & Cook, 2013). A comprehensive approach to treatment, including case 
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management & peer-supports, could aid in addressing issues of poverty, employment, 
and access to services. As a result, patient’s treatment attendance would be enhanced, 
leading to a more positive outcome. This study was not able to provide clarity on the 
mechanisms by which financial struggles impact treatment success. Future research will 
be needed to determine the overlapping influences of financial stability, employment 
opportunities, coverage of treatment costs and other aspects of treatment which may 
impact recovery. 
The results of this study have important implications for several variables which 
are believed to be clinically meaningful, including age, gender, and psychological 
distress. Within this study, age was not supported as a predictor of treatment outcome, 
however, the age of first drink was. Thus, perhaps for alcohol treatment, “age is just a 
number,” while early drinking behavior is a meaningful predictor of difficulties in 
recovery. Of interest, this falls in line with Johnson, et al.'s (2000) conclusion that age of 
onset may provide insight into possible ‘types’ of drinking groups. 
An additional, surprising finding was that gender did not predict treatment 
outcome. This is in contrast to literature demonstrating that females are more likely to 
have short-term remissions in alcohol use (Adamson et al., 2009; Moos & Moos, 2006). 
Given the strong representation of females (37%) it is unlikely that this finding is due to a 
lack of statistical power in the current sample. Thus, (at least) three potential explanations 
are possible. First, perhaps Day One differentially enhances male-specific recovery. This 
is unlikely, given that several modifications to Day One IOP treatment were more likely 
to benefit the recovery of females, including access to a female clinician, a group for 
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expectant mothers, and a weekly women’s group. The second alternative, could be the 
presence of reduced disparity between men and women, including many which have 
previously been suggested to influence gender-based differences in treatment outcome. 
These could include severity of baseline alcohol use, co-occurrence of internalizing 
psychological disorders, educational attainment, and responsiveness to treatment (Litt et 
al., 2015; Mann et al., 2004; McCutcheon et al., 2014; Sugarman et al., 2013). Finally, it 
is possible that gender no longer effectively measures the underlying trait which predicts 
engagement/disengagement from alcohol use behaviors. Women’s integration of 
dominance masculinity (e.g., being aggressive and forceful) and men learning to hold 
opposing gendered self-concepts (i.e., traditionally feminine beliefs) may result in more 
equivalent patterns of use and, likely, recovery (Clinkinbeard & Barnum, 2017; Likis- 
werle & Borders, 2017; Lyons & Willott, 2008). As such, these results could suggest that 
it may be time to let go of gender-based beliefs within recovery and seek for a deeper 
level of understanding. 
Based on abundant literature, it was surprising that while specific measures of 
depression and anxiety were related to treatment outcome; suicidality and the broader 
measure of psychiatric severity within the Addiction Severity Index were notably absent. 
This suggests that refined measures of specific psychological symptoms may be a more 
useful approach than a broad measure of psychological distress. Given the strength of 
psychological distress as a predictor in the literature (Colder et al., 2017; Hill & Angel, 
2005), it may be that the Addiction Severity Index isn’t a sufficient measure, perhaps 
because it measures addiction related pathology rather than mental health symptoms 
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more generally. Thus, in future studies it will be useful to examine specific diagnostic 
groups (e.g., assessing Panic Disorder, OCD, ADHD, Anger/Aggression/Anti-social 
Personality Disorder, etc.) or to measure psychological distress not related to substance 
use problems. 
Taken together, the data-driven analysis of the Day One Intensive Outpatient 
treatment program, highlights the importance of characteristics of the individual when 
they begin treatment (their level of alcohol use, anxiety and depressive symptoms, 
comorbid substance use, and motivational stage) as well as their engagement during 
treatment. Alternatively, decreasing attention to specific demographics, non-specific 
mental health measures, and reasons for non-attending treatment sessions will likely 
support all patients’ ability to utilize the effectiveness of IOP services. 
Strengths and Weaknesses of the Elastic Net Regularized Regression Approach 
 
The Elastic Net Regularization approach, in combination with cross-validation 
was selected to identify predictors of the treatment outcome while preventing model 
overfitting and enhancing generalizability. In this approach, a sub-set of the data is set- 
aside, so that final model testing occurs on a new set of patients who were never used in 
model generation. This is a significant advantage over traditional approaches which are 
known to have poor replicability and generalizability (Whelan & Garavan, 2014; Zou & 
Hastie, 2005). 
In order to test the replicability of the results generated with the Elastic Net 
Regularization approach, multiple models were generated and evaluated in selecting the 
most important predictors. We chose to evaluate the frequency of predictor variables as a 
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measure of their importance (i.e. those variables that were important in every model are 
presumabley better predictors than those that are only identified in 10% of the models). 
Rationale for this choice comes from recognition that the number of variables in a model 
did not generally increase its’ power (for example a model with 31 variables had only 
slightly better explanatory power than a model with 14 predictors - regression 
coefficients of 0.34488 and 0.32509, respectively). 
There was considerable variability in the explanatory power and number of 
included variables within the fold-based runs. One potential explanation for this is our 
sample size. Though 120 subjects is somewhat representative (Lo Coco et al., 2019), 108 
subject were used to train the model, which was then tested on 12 subjects. Thus, it is 
apparent that the predictors cannot be evenly distributed during the randomization of 
patient’s into testing sets. Indeed, heterogeneity characterizes individuals engaged in 
patterns of unhealthy alcohol use, a primary reason for studies like Project MATCH 
(Allen et al., 1997; Connors et al., 1998; Pagano, Friend, Tonigan, & Stout, 2004; Project 
Match Research Group, 1998). As such, increased sample size might have yielded an 
even stronger model. 
Another potential to consider are the similarities and differences in the patterns of 
variables that appear within the final models, with a focus on a conceptual framework of 
recovery. It is possible to consider this concept via, at least, two different interpretations. 
The first being Johnson and colleagues' (2000) concept of a proxy risk variable, that the 
predictors identified within this study are actually imperfectly measuring a broader 
concept.   Given the assumption of inclusion of all relevant variables within the study, 
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performance of factor analysis could support the identification of conceptual parity. The 
second consideration follows from difficulty assuring the assumption of having 
completely assessed all variables which may contribute to the course of recovery. The 
need to return to the literature for possibly missing content will be further addressed 
within the limitations section, below. 
Objective II: 
 
The second objective tested a theoretically-derived model of factors to predict 
treatment outcome. The model of recovery depicted in Figure 2 posits that factors from 
all levels of the Bronfenbrenner model are important, and that psychological distress will 
mediate the relationship of the variables to treatment outcome. Results showed 
significant direct effects of readiness to change, initial frequency of alcohol use, and 
having a primary care physician. As the influence of the first two variables have been 
previously discussed, we will focus on the implications of having a primary care 
physician. The contribution of a primary care physician to improve treatment outcomes 
suggests that some level of engagement with medical treatment may be beneficial. There 
is also the potential that this is a proxy risk factor, perhaps representing the individual’s 
stability within their community or their socioeconomic status. 
The finding that psychological distress did not mediate the relationship between 
any of the predictors and outcome was surprising. This may be because of the limited 
number of variables which were significantly related to psychological distress. Though 
not a requirement for mediation, this would indicate some weakness within the model 
structure. However, the lack of a significant relationship between psychological distress 
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and treatment outcome is a true weakness in the theoretical model. Given the relatively 
weak correlation prior to analysis, it may be suggested that this single measure of 
depression is insufficient for the demands of mediation. An alternative strategy could be 
to derive a psychological distress variable using factor analysis, which may be both more 
effective and theoretically-consistent (Hill & Angel, 2005). However, there are not 
enough psychological variables in the dataset for this to be feasible. The indirect effects 
are also problematic in that while they are statistically significant, for readiness to 
change, initial frequency of alcohol use, and access to a primary care physician, each has 
confidence intervals which overlap zero. This demonstrates that the relationships are 
weak (i.e. the mediational path does not improve prediction over the direct path). 
Therefore, the results of this analysis should be interpreted with great caution, and alone 
cannot advance our understanding of recovery within the field. 
Taken together, the results of the theoretically aligned mediational analysis 
suggest limited benefit for improving a general understanding of recovery from alcohol 
use disorder for several reasons. First, the process of variable selection (though consistent 
with general practices) is biased by removal of non-correlated variables which are thus 
not accounted for in the final analysis. Secondly, this method generates results that are 
inherently specific to the sample of patients included in this study, resulting in overfitting 
of the model, making application to wider populations untenable. 
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Integration of Data- and Theory-Driven Research: 
 
The final consideration of this study is the comparison between analytic methods. 
 
Notably, the direct comparison between a modified regression analysis, such as the 
Elastic Net Regularization approach with cross-validation, and the mediation model 
results in elements which are not directly relatable. There are, however, several 
overlapping results across the two analytical methods. It may be that these represent a 
“true” relationship as they are supported by both theoretically and data-derived analyses. 
Alternatively, it may be that these variables represent a specific effect of the study’s 
sample, though the Elastic Net Regularization methods makes this unlikely. The 
significant predictors in objective two (readiness to change, initial frequency of alcohol 
use, and access to a primary care physician at onset) were also in the high frequency 
group of predictors for the primary analysis with the same direction of effect, which 
would imply an inherent relationship. Finally, three variables are noted to lack a 
significant relationship to treatment outcome, which again aligns with the development of 
a model with some level of generalizability. The results do, however, demonstrate some 
overfitting to the study sample, occurring in the increased strength of the coefficients for 
the significant variables within the mediation analysis, including readiness to change 
(Objective I: -0.095; II: -0.591), initial frequency of alcohol use (I: 0.022; II: 0.271), and 
primary care physicians (I: -0.170; II: -2.196). Overall, these results demonstrate the 
marked benefits of implementing a data-driven approach, including an enhanced capacity 
for demonstrating significant predictors of treatment outcome and improvements in the 
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perceived ability to apply these results to the broader community of patient’s recovery 
from unhealthy alcohol use. 
Limitations/Future Directions 
 
As noted above, there are several areas within this study which could benefit from 
further examination to strengthen generalizability of our results to the field of recovery. 
These include decisions made in the analytic process and limitations in the selection and 
measurement of the variables that were collected. In terms of the analytic approach, the 
decision to complete a simple replacement of missing variables according to the 
mean/median of the sample could be a concern. An alternative approach of utilizing 
multiple imputation may have benefitted the results by increasing the individual-specific 
variability for each piece of missing data rather than relying on the central tendencies of 
the group. Given the relatively limited amount of missingness (particularly after variable 
exclusion), the amount of impact that this manipulation would have on our results cannot 
be easily determined. Similarly, it should be noted that when using data-driven methods, 
there are choices made in setting up the framework which affect the results. For example, 
while the choice of a 10-fold cross validation is well-represented within the field (Zou & 
Hastie, 2005), an argument could be made for using 5-fold (to increase sample size in 
each fold) and/or a 20-fold (to improve replicability) cross validation setups. Thus, in the 
absence of clear evidence for the optimal structure, we chose to use methods that have 
been demonstrated to be robust in similar sample sizes. 
Within the second objective, we noted the potential utility of using factor analysis 
to detect latent variables. This is particularly relevant in the context of defining 
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psychological distress – as a latent variable may better capture variability in mental 
health profiles when compared to a unitary measures of depression, anxiety (which were 
collected using the Beck instruments), and substance-related mental health issues (as 
done on the ASI). Unfortunately, there were not enough mental health items collected in 
this study to use this method. Considering the best-practices for selecting which variables 
are entered into a model will likely require a balance of taking from the literature and 
examining the influences of the collected data, a goal of future work. 
In this dataset, there were several limitations which are associated with the data 
itself. First, as Day One provides services primarily to Chittenden County in Vermont, 
the demographics reflect those of its’ residents. With Vermont being reported by the 
United States Bureau (2016) to be primarily Caucasian (93.1%), racial diversity may be 
the largest influence on our study sample. Additionally, the sample of participants is 
influenced by the patient’s level of need and the accessibility of other local treatment 
facilities. At the time the data was collected, alternative services for the treatment of 
unhealthy alcohol or substance use primarily included inpatient and peer-support based 
treatment (i.e., AA). In addition, the sample of patients may be impacted by the focus on 
an abstinence-based model of care within Day One. This suggests that individuals in 
immediate withdrawal, those swayed toward a peer recovery process, and those 
disinterested in abstinence-based recovery may not be included in this study sample. 
The choice of selecting patients who initiated treatment within a single year may 
also impact the results. Though this study used retrospective data from 2011 to 2012, the 
landscape of drug and alcohol use and treatment has changed dramatically in the last 8 
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years. Influences of the opioid epidemic include a strain on treatment center resources, a 
change in the patient population at Day One, and a higher rate of co-morbid alcohol and 
drug problems. Therefore, it is unknown if the results of this study will be the same for 
those seeking treatment today. However, the inclusion of subjects with all types of co- 
occurring drug use and mental health problems; as well as the use of cross-validation 
strengthen the generalizability of these findings 
The source data came from patient clinical records. This is a strength in that the 
data is directly relevant and feasibly collected in community-based treatment centers. 
However, there were limits to variables that were available including inconsistent 
sampling of urine toxicology. In the context of treatment at Day One, urine drug tests are 
ordered for clinical reasons. Therefore, patients are not equally assessed, with those who 
were successfully abstinent being tested less often than those who experienced lapses. 
Further, Alessi, Petry, & Barnett (2019) provide data that self-reporting use and UDTs 
may be out of date, with information that transdermal measurement of alcohol use can 
provide an accurate and timely measurement of use that may enhance and direct 
interventions. 
There is always a trade-off between the ideal research assessments and the ideal 
clinical assessments (with the research assessments usually being longer and more 
expensive than is feasible clinically). However, the study results would be strengthened 
by standardized measures assessing patterns of substance use (i.e., Timeline Follow-Back 
and/or Concurrent Recall; Sobell et al., 2003), components of socioeconomic status 
(Townsend Index and/or Duncan’s Socioeconomic Index; Shavers, 2007) and 
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psychological distress (Psychological Distress Manifestations Measurement Scale; 
Masse, 2000). The standardized measures that were used, i.e. the Addiction Severity 
Index, may influence the information provided by the sub-components of family/social 
distress, health status, and employment status given the overall focus on assessing the 
impacts of substance use. 
Finally, this study followed the clinical treatment course, which included data 
collected at clinical time points (i.e. intake assessment, in-person interview, during 
treatment, etc.), and there were different durations between these timepoints between 
participants. This may have been particularly relevant for our second objective as the 
psychological variables were collected once during the intake paperwork. Ideally this 
would have been collected after the initial predictors and at multiple timepoints to assist 
in determining an influence through the mediator and possible changes over time. Many 
of the other variables included in this study are not stagnant and will demonstrate 
significant and important change throughout treatment, i.e., readiness to change. As such, 
focus on advancing the clinical utilization of assessment throughout IOP treatment will 
be important for future research. 
It is also important to consider the variables that were and those that were not 
measured. First, we will consider general aspects of the initiation of and engagement in 
treatment that facilitates recovery. The process of self-selection into treatment may be 
important to acknowledge (e.g., Cutler & Fishbain's [2005] attending zero sessions has 
better outcomes than one session). It is difficult to measure the inherent elements of the 
therapeutic skills demonstrated by frontline-clinicians, including the examination of 
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stigma, pros/cons of independent recovery, uncertainties surrounding treatment 
engagement, development of therapeutic alliance, evocation of change talk, and 
flexibility with barrier to change. Below we discuss variables that could be considered in 
future studies using the Bronfenbrenner model, including variables at the level of the 
individual, microsystem, mesosystem, and macrosystem. 
At the level of the individual there are several variables that would have been 
ideal to include. For example, measures assessing the underlying elements of gender, 
such as Dominance Masculinity (Bem Sex-Role Inventory; Clinkinbeard & Barnum, 
2017), will likely aid in clarifying the aspects of gender that are connected to differences 
in recovery outcomes within the literature more broadly. Similarly, the development of 
contextual knowledge about the specific motivations for drinking (Kuntsche et al., 2008) 
and maintaining use of alcohol (Relapse Motivations [Zywiak et al., 1996]) would add 
important context to an individual’s trajectory of recovery. An increased focus on 
integration between the fields of psychology and biology has begun to open the door for 
the assessment of both emotional reactivity and emotional regulation via variables like 
respiratory sinus arrythmia and skin conductance (Colder, 2001; Heilig, Thorsell, et al., 
2010). While these are not typically collected clinically, they would add rich data that 
might be useful in predicting treatment outcome as they are rooted in neurobiology. 
Future research will also benefit from understanding how the social environment 
and relationships influence recovery. The literature suggests marked and separate 
influences for both family support (Dobkin et al., 2002; Edwards & Steinglass, 1995; 
Miller et al., 1999) and friend/social support (Best & Lubman, 2017), which may differ 
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based on characteristics of the individual (Groh et al., 2007; Litt et al., 2015; Mavandadi 
et al., 2015; McCutcheon et al., 2014). Such complexity may contribute to confusion in 
what to measure and how to consider these factors within treatment. It appears that the 
most consistent components to assess would be beliefs about alcohol use perpetuated by 
family/friends, general family/friend support, and specific family/friend support for 
recovery. As these are assessed in future work, further clarity is likely to be identified in 
patient responsive to specific interventions relative to the source (family versus friend), 
type (general vs. specific) and degree of social support. 
Finally, the broadly-based contributions of the community and society could be 
measured with variables such as neighborhood disorder and community-wide 
permissibility of use. Inclusion of these factors may help to understand systemic barriers 
to treatment. Further, assessment of the influences of societally-held beliefs about the role 
of alcohol (drinking cultures) may further aid in normalization of the difficult process of 




This study demonstrates the application of big data methods to clinical outcome 
research and highlights the strengths and weaknesses of both theory- and data-driven 
methodologies. Interestingly, the theoretically-driven analysis completed in this study 
revealed limited benefits of application to the field of recovery. Using Elastic Net 
Regularized linear regression allowed the inclusion of a wide group of variables and 
resulted in selection of variables that independantly contribute to prediction of outcome. 
The results will guide treatment refinement, specifically supporting increased focus on an 
indiviudal’s initial use profile, mental health symptoms, motivation for change, use of 
other substances, and treatment engagement. They also demonstrate placing an emphasis 
on encouraging treatment attendance (even when there are occassional missed sessions). 
Similarly, the results suggest de-emphasizing demographic predictors including age and 
gender. As such the continued implementation of data-driven methodology will aid us in 
re-defining unhealthy alcohol use to involve the process of balancing self-efficacy and 
temptation in alignment with current patterns of use, psychological distress, availibility of 
specific treatment and social supports, as well as the potential involvement of broadly- 
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Description of the Day One Treatment Program by Messina, Keithcart, Brown, Dees, and 
Reed (In Progress): 
The setting for this report is the midlevel outpatient substance abuse 
rehabilitation program at the University of Vermont Medical Center. The 
program is identified as the Day One program, a division of Psychiatry, 
University of Vermont Medical Center, and is the clinical component of a major 
research center studying cocaine, opioid, alcohol, and nicotine use. The facility is 
located in Burlington, Vermont on the UHC campus. 
It serves the Chittenden County region (population 156,545 based on the 
2010 census), but because Vermont is a rural state, it draws patients from distant 
counties and townships, including Addison, Washington, Lamoille, Franklin, 
Orleans and Grand Isle. It also receives referrals for treatment from many out of 
state residential treatment facilities. It interfaces externally with detoxification, 
residential and outpatient programs locally and throughout the state. Within the 
University of Vermont Medical Center Health Care system, it serves the needs of 
patients, employees and students and is linked with inpatient psychiatric services 
and midlevel outpatient mental health services, which provide partial 
hospitalization and intensive outpatient treatment to patients who do not actively 
use substance. 
It was the Department of Psychiatry’s intent, when they recruited a 
psychiatrist as medical director of Day One, to expand the services to include 
treatment of co-occurring disorders. The design was intended to enhance the 
treatment and educational program by integrating services. 
Generally speaking, the outpatient treatment of co-occurring disorders 
has varied widely. While there has been a strong emphasis on integration, 
considerable barriers have been identified that have prevented implementation. 
The result has been an assortment of programs that include coordination of 
treatment, sequential treatment, co-location, partial integration (conforming to 
the parallel approach) and full integration (Mangrum, Spence & Lopez, 2006). 
The essential features of the fully integrated Day One program is a dually-trained 
staff and simultaneous treatment where one team, staffed by licensed alcoholism 
and drug counselors (LADCs) and the psychiatrist, coordinate the treatment plan 
and co-manage the treatment throughout the progression of the patient’s care. 
… 
Staff 
The staff includes an administrative assistant and four licensed 
alcoholism and drug counselors; one clinician is also certified in mental health 
and leads the co-occurring disorder intensive outpatient group. One member of 
the staff serves in the position of clinical supervisor. The LADCs are masters 
level counselors and required, to complete 2000 post-graduate supervised work 
hours in order to be licensed in the state of Vermont. They are trained in both 
substance abuse and psychopathology. An onsite, half-time psychiatrist, who 
serves as medical director, completes the treatment team. The team jointly shares 
responsibility for patient care and participation in continuous staff training and 
medicine/psychiatry resident and graduate education in alcohol and substance 
treatment. The staff meets twice weekly with a clinical and administrative 
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agenda. The clinical team collaborates closely to assign appropriate treatment 
levels, to identify high-risk patients, develop risk management measures 
(Cornelius et al., 1995), review treatment plans and communicate and agree 
about probable COD patients appropriate for referral for psychiatric evaluation, 
consultation and perhaps treatment. Team members regularly conference on an 
impromptu, as-needed basis regarding patient issues. 
The team jointly decides level of care and pace, timing and disposition, 
as patients transition through treatment and progress into remission over the 
course of program participation. Pharmacotherapeutic rationale and response to 
medication, as well as degree of psychotherapeutic engagement are regularly 
discussed and shared. Provisions for relapse prevention and long-term medication 
management are addressed. 
Admission Process 
Admissions begin with a phone call contacting the administrative 
assistance, who responds to inquiries, answers questions and explains the 
admission process. 
Day One uses a two part procedure to adequately assess a prospective 
patient and determine appropriate level of care. 
The first part consists of completing pre-admission paperwork, which 
includes insurance information, confidentiality agreement, reasons for referral, 
primary and social environmental supports, mental health history, educational 
background, occupational history, housing situation, interactions with legal 
system, medical history, pain assessment, dietary concerns, alcohol and drug 
history, AIDS risk assessment and participation agreement. In addition, the 
following assessments are obtained: Beck Anxiety Inventory, Beck Depression 
Inventory 2, Beck’s Suicide Scale, and the Addiction Severity Index multimedia 
version connect. The patient completes the preliminary information prior to being 
scheduled with a counselor to improve the show rate for the screening 
appointment. 
The second part is a screening evaluation to assess the patient’s drug and 
alcohol history, psychiatric history, current mental status and level of risk. The 
evaluation will determine the appropriate level of treatment based upon 
American Society of Addiction Medicine (ASAM) criteria. The clinician reviews 
all documents and assessments before meeting with the prospective patient. The 
patient’s motivation for treatment and current stage of change is determined. If 
the patient meets criteria and agrees to treatment services at Day One, additional 
information is obtained. Consent for treatment and release of medical 
information forms, are signed; emergency contact is identified and ADAP 
(Agency of Drug and Alcohol Program, state of Vermont) admission information 
is collected. Additionally, collateral contact information is obtained through the 
consent to release confidential information forms and self-report of current use 
status is confirmed by urine screen. 
The patient’s treatment plan is written during the evaluation. The 
treatment plan consists of the following informational and problem areas 
described and written in the patient’s words: Alcohol/drug, psychiatric/medical, 
family/social, legal, housing, vocational, recreational, and other. Goals and 
quantifiable measures are established for each problem area with time-limited 
objectives; connection is made with responsible person for assistance in meeting 
goals. The patients assist in prioritizing the problem areas. Related strengths and 
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assets are described in the patient’s words. Estimated length of stay, treatment 
contacts, date of treatment plan and review/update are determined before the 
patient signs and is given a copy of the treatment plan. 
Treatment Process 
Substance abuse treatment occurs in the context of a group 
psychotherapy process. The program is divided into three group levels. 
a. The Intensive Outpatient Program (IOP). The intensive outpatient 
program, with a focus on co-occurring mental health disorders, meets 3 times 
weekly for 3 hours. The group capacity is 10 members and the typical length of 
stay is 9 to 12 sessions. The length of stay may be extended based on the 
individual’s needs. If an individual is unable to achieve stabilization in the IOP, a 
higher level of care, such as residential, is typically recommended. The IOP 
program offers an environment of safety and structure addressing stabilization of 
co-occurring challenges. The program’s goal is that group members develop the 
necessary coping skills to manage co-occurring psychiatric conditions and 
addiction. Emphasis is placed on how these two conditions impact each other and 
what goals need to be accomplished to promote a successful remission. Every 
session begins with a meditation/mindfulness practice, where members are 
introduced to the benefits of diaphragmatic breathing and the concept of 
mindfulness in an effort to learn “quiet body/quiet mind.” This also affords the 
opportunity for group members to experience grounding prior to beginning the 
process time during the group session. Group therapy emphasizes safety, 
validation and consistency which leads to better group cohesion. Group members 
are often referred to the medical director for psychiatric services to address co- 
occurring issues such as anxiety disorders, depression, PTSD, and other 
conditions, which become more evident with abstinence. Accommodations are 
made for prompt psychiatric evaluation and medication management, as 
indicated, for those with acute psychiatric needs. 
The group therapeutic techniques include emotion regulation, 
mindfulness practice, group psychotherapy, motivational enhancement, cognitive 
behavioral therapy, relapse prevention, coping and life skills training. Skill 
building is offered with an array of psychoeducational tools including worksheet, 
experiential exercises and substance use disorder videos. Random urinalysis is 
always provided to verify self-report. Once an individual has successfully 
stabilized, as indicated by the ability to maintain abstinence, acquisition and use 
of coping skills, development of relapse prevention plan and compliance with 
psychiatric care as indicated. They transition to lower level groups within the 
Day One program. Some may be referred for expanded psychiatric treatment in 
the outpatient mental health program, which is located in the same building, 
while maintaining coordination of treatment and continuity of care with the Day 
One psychiatrist. 
A second Day One IOP is led by a single facilitator and is composed primarily of 
patients with substance used disorders only. 
b. Level II. Day One’s step-down level II group is part of a continuum of 
services provided within the framework of client-centered therapy. Level II 
groups meet 2 times per week for 2 hours each group. Level II groups have a 
rolling admission and each member will attend at least 9 sessions and upward of 
16 sessions, depending on the stabilization of the individual patient. 
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A level II patient has been deemed sufficiently stable, within their 
substance use and/or mental health process, to manage attending therapy at a 
reduced level of time and intensity. This is determined by the primary therapist 
and the clinical team. Level II patients can anticipate a shift in treatment 
approach from level III where a more structured, skill-driven process exists, to 
one of the patient’s being encouraged to “ask for what they need.” The group 
therapy sessions offer a more psychodynamic approach with emphasis on group 
interaction, feedback and honest communication of emotions. This is not to say 
that the group psychotherapy model does not occur at higher levels of care, but 
rather that patients are now more stable in their remission and can explore more 
stressful events without resorting to former modes of coping. 
The patients are expected to participate during all activities, including: 
Mindfulness meditation, which begin each session, check-ins, which include any 
use of mood altering substances, level of urge to use (LOUU) from 0 to 10, 
subjective unit of disturbance scale {SUDS) from 0 to 10, active listening, 
claiming personal use of time in group, participating in all educational sessions 
and discussions and providing random urine screenings on request for 
verification. The patients may continue seeing the program psychiatrist for 
medication management and/or therapy. Often, when patients first become aware 
of their co-occurring disorder and learn that they must simultaneously manage 
their substance use disorder, and their mental health issues, having a group to 
turn to can be very reassuring that they do not have to do this alone. 
c. Level I. When the patients have achieved goals at level II, they are 
offered the option of continued care in level I groups, which meet weekly for 90 
minutes. Level I goals include providing a continuum of care to assist patients in 
expanding their skill set, enhancing their understanding and management of 
relapse triggers and gaining insight into their substance use disorders. This group 
level tries to engage patients at their level of ability and psychosocial 
competence. 
Day One level I groups include 2 weekly cognitive behavioral therapy 
(CBT), a group for expectant mothers addicted to opioids, a weekly women’s 
group and two long-term relapse prevention groups, which meet weekly and 
biweekly. The 12-session protocol outlines a spectrum of skill enhancement 
objectives to foster mindfulness as the patients learn to manage urges and 
cravings, add structure to their lives, exercise boundary setting, embrace 
accountability and improve judgment. Mindfulness training is a natural segue to 
psychosocial and mental health issues commonly associated with substance use 
and underscores the application of the biopsychosocial model of disease. 
The long-term relapse prevention groups strive to establish stability and 
maintenance of remission while more effectively managing the naturally 
occurring uncertainties and unpredictable setbacks of daily living that frequently 
undermine remission from alcohol use. 
A prime example of the level I process is the women’s group. A weekly 
women’s remission group is offered to address the unique needs of women in 
remission. Some typical goals of the group are sustained abstinence, stress 
management, empowerment, breaking the cycle of co-dependency and 
relationship issues. Most of the women entering the group have a trauma history 
and often are engaged in individual therapy addressing trauma-related issues. The 
group can provide additional support, specifically with development and practice 
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of safety skills, resource installation and coping skills to effectively manage 
PTSD symptoms. 
Women entering the group will be exposed to meditation/mindfulness 
practice and grounding techniques. Skill building around interpersonal skills, 
assertiveness, self-soothing and stress reduction are primary goals. Offering a 
safe, consistent, validating, therapeutic environment is key for the growth of 
group members. The group is intended for long-term support and women tend to 
build strong alliances in the group as they explore their journey into remission 
together. 
d. Psychiatric Care in Day One. While patients engage in group- 
psychotherapy at Day One, stepping down from level III to level I, compliance 
with ongoing psychiatric care, which some patients may elect to receive from the 
Day One medical director or outside the Day One program, is encouraged and 
monitored in a collaborative manner. The Day One psychiatrist provides a 
combination of pharmacotherapy, medication monitoring and psychotherapy on 
an individual basis as indicated. The patients are seen regularly (as often as 
weekly), for treatment, which utilizes an eclectic approach including 
motivational enhancement therapy, cognitive behavioral therapy, 
psychoeducation, psychodynamic therapy, and supportive therapy. The degree of 
engagement varies. Some patients maintain sobriety, complete the first 3 levels 
of the Day One treatment program and remain in long-term treatment in the 
relapse prevention group and with the psychiatrist for medication management 
and relapse prevention. This extended treatment aspect of the program has 
enhanced continuity of care as a unique feature of the program. 
